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ABSTRACT

Mold, Allergic Diseases and Asthma: Assessing the Validity and Usefulness of Indoor Air
Sampling as a Tool in Providing Health Protective Advice to Occupants
by
William M. Sothern

Advisor: Jean Grassman
Background: Asthma is a major health problem throughout the world, disproportionately
affecting occupants of low-income housing, and exposure to damp and moldy living conditions
is recognized as a significant risk factor for asthma and other respiratory diseases. However,
there are no authoritative health guidance values (HGV's) for airborne mold, and current
scientific thought holds that the establishment of such guidelines is not practicable. Nonetheless,
environmental practitioners take air samples for mold as a routine component of their indoor
environmental investigations and use the laboratory results as a tool together with other findings
to guide recommendations for health protective actions. The absence of HGV's leaves the task of
risk assessment to the environmental practitioner, which has led to inconsistent interpretations of
laboratory results, undermining their credibility in the eyes of clients, physicians and the
courts. Researchers have concluded that current scientific evidence does not support the
measurement of specific indoor microbiologic factors, including airborne mold, but have
recognized the need for rigorously designed studies that will contribute to the development of
dose-response based HGV's.
Objectives: To assess the validity and usefulness of indoor mold air sampling results as a tool in
providing health protective recommendations by: 1) examining the current body of scientific
evidence that supports or rejects the validity of measuring indoor airborne mold levels in
assessing respiratory health risk to atopic occupants; 2) conducting a study where the results
would help to define a dose-response based quantitative benchmark for elevated levels of indoor
airborne mold that present a respiratory health risk to atopic occupants, and; 3) assessing
whether indoor airborne mold sampling results can be used as a tool to enable physicians to more
accurately diagnose mold allergies by more closely aligning the mold antigen extracts used for
skin and serum testing with the predominant genera and species of mold found in damp and
moldy homes.
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Methods: To accomplish these three objectives: 1) a systematic review was conducted that
identified and isolated peer-reviewed observational studies published from 1989-2017 that
measured the strengths of association between exposure to elevated levels of indoor airborne
mold and asthma or other adverse respiratory health outcomes and that met the inclusion criteria
of having assessed those associations by genus/genera and having accounted for susceptibility
bias, and then evaluated the homogeneity of findings and the criteria used to define elevated
levels of airborne mold; 2) a nested case-control pilot study was conducted where indoor
airborne mold samples and outdoor controls were collected from the homes of 34 six and seven
year-old children, randomly selected from within the 1,543 member Infant Wheeze Cohort in
Havana, Cuba to assess the level at which exposure to Penicillium/Aspergillus-type mold in the
indoor air presented a significantly increased risk of wheeze, and; 3) a database of laboratory
results was built for all culture-type air samples taken by environmental practitioners across the
U.S. and Canada from 2002-2017 and analyzed by a major U.S. microbiology laboratory to
determine the predominant genera and species of molds found in damp and moldy homes, and
then concordance was assessed between these results and information provided by physicians
and clinical laboratories as to the species-specific mold antigen extracts used in the diagnosis of
mold allergies.
Results: 1) The systematic review found that 20 of the 21 studies that met the inclusion criteria
found significant associations between exposure to elevated levels of indoor airborne mold and
one or more adverse respiratory health outcomes, irrespective of the wide range of criteria used
to define elevated levels, and that the mold most commonly associated with these outcomes was
Penicillium. 2) The nested case-control study found that children exposed to
Penicillium/Aspergillus-type mold where indoor levels exceeded outdoor levels by > 200
structures/m3 were at significantly increased risk of wheeze (OR 13.17 95% CI,1.95-88.85). 3)
The concordance study found that species representing > 50% of the Aspergillus fungal
organisms and > 80% of the Penicillium fungal organisms found in damp and moldy homes are
absent from the species-specific mold antigen extracts used by clinicians to diagnose mold
allergies.
Conclusions: 1) The systematic review finds that current scientific evidence does support
measuring mold in the indoor air as a tool in providing health protective advice to atopic
occupants, but the evidence does not provide a basis for establishing HGV's for indoor airborne
mold. 2) The nested case-control study suggests that defining elevated levels of airborne mold as
indoor levels of Penicillium/Aspergillus exceeding outdoor levels by > 200 structures/m3 may be
a useful benchmark for examination in larger similarly designed studies. 3) The concordance
study suggests that mold allergies are being under-diagnosed by physicians resulting in the
under-recognition of the need for environmental interventions that may improve patient
outcomes, and that improving concordance will require a coordinated effort between clinicians
and mold antigen extract manufacturers.
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CHAPTER 1
INTRODUCTION
Specific Aims
Over 24 million Americans or 7.8% of the U.S. population suffer from current asthma (defined
as having suffered an asthma episode within the last 12 months), and over 6 million or 8.4% of
American children suffer from current asthma, making asthma the leading chronic disease
among children in America.1 Three major systematic reviews (IOM 20042, WHO 20093, Mendell
et al. 20114) have concluded that there is “sufficient evidence of an association” between
exposure to dampness in indoor residential and school environments and significantly increased
risk of asthma, cough, wheeze, upper respiratory symptoms and hypersensitivity pneumonitis.
The World Health Organization (WHO) has defined the markers of dampness as visible mold,
visible water damage, visible or measurable excessive moisture and/or a musty odor.3 However,
the authors of the Institute of Medicine (IOM) and WHO reviews found that there was
insufficient evidence on which to base quantitative values for mold levels that would present a
respiratory health risk to atopic occupants, and the authoritative and widely cited 2011
systematic review conducted by Mark Mendell of the CA Department of Health/Berkeley
National Laboratory et al. (479 citations) goes even further, concluding that “current evidence
does not support measuring specific indoor microbiologic factors to guide health-protective
actions.”4 However, Mendell recognizes the need for further research, and in 2015 published A
Research Agenda on Assessing and Remediating Home Dampness and Mold to Reduce
Dampness-Related Health Effects (supported by the U.S. Department of Housing and Urban
Development) that poses a series of research questions that need to be answered by new and
rigorously designed studies which will contribute to the development of quantitative health
guidance values for dampness and mold (D/M).5 In response to that challenge, we propose to
conduct two studies that would examine the validity and usefulness of measuring the mold in
indoor air subset of specific indoor microbiological factors. Indoor air sampling for mold is
routinely conducted by environmental practitioners as part of their indoor environmental
assessments in homes where occupants report respiratory health symptoms and/or water damage
and mold concerns (complaint homes), and the associated laboratory results are used together
with other findings to guide recommendations for health protective actions. We also propose to
conduct a third study that would examine the usefulness of air sampling for mold to the clinical
community. We hypothesize that the results of these three studies will both add to the body of
evidence that validates and supports the use of and usefulness of this methodology and help to
establish baseline quantitative minimum risk levels for indoor airborne mold that can be tested
for reliability in future studies. The specific aims and methods of these three studies are outlined
below:
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1. Study 1 - Assess the homogeneity or heterogeneity of findings in studies that examined the
associations between exposure to elevated levels of mold in indoor air and adverse
respiratory health outcomes by conducting a systematic review using evidence-based
inclusion criteria, and examine the criteria used in these studies to define elevated levels.
2. Study 2 - Establish a quantitative dose-response based benchmark for genera-specific
airborne mold above which there is a significant respiratory health risk (wheeze) to atopic
residents of D/M homes by conducting a nested case-control study in Havana, Cuba.
3. Study 3 - Assess the concordance or discordance between the predominant genera and
species of mold found in the indoor air of complaint homes and the genus and speciesspecific antigen extracts used by physicians to diagnose mold allergies by creating a database
comprised of 15 years of culture-type air sampling results and interfacing those results with
information provided by physicians and clinical laboratories as to the species-specific mold
antigen extracts used in the diagnosis of mold allergies.
Mold Exposure and Asthma – Quantitative Risk Assessment
The public health importance of establishing quantitative risk levels or health guidance values
(HGV’s) for airborne mold has been widely recognized by government agencies and professional
organizations for decades, as evidenced by the efforts of many organizations including the
WHO, the NYC Department of Health and Mental Hygiene, the Commission of European
Communities, the Canada Health and Welfare department, the American Industrial Hygiene
Association (AIHA), the American Conference of Government Industrial Hygienists (ACGIH)
and the Indoor Air Quality Association, which have published quantitative health risk levels for
airborne mold (see Chapter 2, Supplemental Data S-1). However, these recommended exposure
limits were based on the personal experiences of environmental practitioners or cross-sectional
sampling surveys that were used to define normal vs abnormal levels and types of fungi, and
were not based on dose-response health effects data. In each case, these guidance levels were
withdrawn, allowed to expire or not renewed in subsequent publications issued by those
agencies/organizations.6 Currently, there are no authoritatively established risk levels for
airborne mold, leaving the decision-making task of assessing the risk inferred by laboratory
results up to the professional judgement of the individual environmental practitioner. This has
led to inconsistent interpretations of laboratory results, undermining their credibility in the eyes
of clients, physicians and the courts.
Guidance provided by the AIHA for the interpretation of laboratory results related to indoor air
sampling for mold advises environmental practitioners that the presence of significantly higher
levels of fungal genera in the indoor air than in the outdoor air should be considered as
unacceptable from a health point of view7, and recognizes that both culture-type and spore traptype air sampling laboratory results can be used to determine the acceptability of indoor air to
avoid occupant exposures that could trigger allergic symptoms. However, the AIHA does not
provide guidance with respect to the quantitative levels at which mold in the indoor air should be
7

considered acceptable or unacceptable.7,8
The generally perceived inadequacy of scientific evidence supporting a quantitative threshold
limit for mold exposure above which there is a significantly increased risk of asthma and other
adverse respiratory health outcomes to atopic occupants of D/M homes has resulted in the
Supreme and Appellate Courts in the State of NY finding that tenants of apartments in NY who
have been exposed to even the most egregious D/M conditions as a result of landlord neglect and
whose children are suffering from asthma being effectively barred from bringing toxic tort
lawsuits against such derelict landlords. Judges have found in landmark cases that held Frye
hearings, which govern the admissibility of scientific evidence in NY tort cases, that the
association between exposure to mold and asthma and other adverse respiratory health outcomes
has not been sufficiently established9,10,11, thereby depriving tenants who have reason to claim
that their family member’s asthma could reasonably be found to have been caused by their D/M
living conditions of their right to a jury trial.
Mold Exposure and Asthma – Health Inequities
In the early 1990’s, the National Institutes of Health (NIH) sponsored The National Cooperative
Inner City Asthma Study to assess the exposure factors that could account for the high asthma
prevalence rates among children living in inner city areas.12 Prior to the NIH study, very few
research studies had been conducted examining the associations between respiratory conditions
(asthma, wheeze, bronchitis, allergic rhinitis, cough) and exposures to damp indoor
environments and mold. In fact, the systematic review conducted by the Institute of Medicine in
2004 cites only 3 such studies conducted prior to 1990.2 The NIH study recruited 1,528 children
from 8 major inner city areas (Bronx, New York; East Harlem, New York; St. Louis;
Washington, D.C.; Baltimore; Chicago; Cleveland, and; Detroit), and when the study results
were presented in an article published in the New England Journal of Medicine in May 1997, the
authors’ conclusions were focused on exposure to cockroach allergens being the primary factor
explaining the high prevalence of asthma amongst inner city children.12 Although not cited in the
conclusions, a deeper look into the data collected during the study finds that of the 1,286 inner
city children in the study who underwent skin prick testing, 38% tested positive for sensitization
to Alternaria type mold antigens whereas 36% tested positive to cockroach antigens and that
previous reports had indicated a sensitivity rate to Alternaria of only 4%-13% among other noninner city childhood populations.13
Mold growth conditions caused by chronic unresolved water damage problems
disproportionately impact occupants of poorly maintained low-income housing, including NYC
public housing. A 2010 study conducted by researchers at Mount Sinai School of Medicine
found that the prevalence of childhood asthma in NYC public housing, managed by the NYC
Housing Authority (NYCHA), was 21.8%, three to four times higher than in private family
dwellings and two times higher than in other types of apartment dwellings.2
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Certainly, we need to acknowledge that other indoor environmental exposure factors, including
cockroaches, dust mites, and secondhand tobacco smoke,12,13 are contributing to this health
inequity. We also know that having a family history of asthma predisposes children’s immune
systems to responding to allergens that provoke asthma symptoms, and that the stresses of
allostatic load can prejudice a child’s immune system toward an IgE antibody driven immune
response to these triggers (see Chapter I Supplemental Data S-1).
In NYCHA housing, where over 400,000 low-income people reside, water damage and excessive
moisture problems that result in mold growth and consequent resident exposure are so pervasive
that in 2013, the Natural Resources Defense Council (NRDC) with other public interest attorneys
filed a lawsuit against NYCHA on behalf of residents suffering from asthma, demanding that the
plaintiffs be granted protection under the Americans with Disabilities Act and that NYCHA be
required to improve its response to the mold problems considered to be a major driver of the
excess asthma prevalence among NYCHA residents. The plaintiffs prevailed in the lawsuit, and
the US Federal Court judge in the case (Baez v. NYCHA) is providing active oversight to assure
compliance with NYCHA’s obligations in the consent decree through the appointment of a
Special Master.14
Mold Exposure and Asthma – The Environmental Practitioner’s Perspective
Microecologies, the firm that this author founded in 1993 and in which he continues to serve as
chief operating officer, has conducted over 5,000 indoor environmental investigations in
response to occupant concerns about D/M conditions. The firm has also conducted many pro
bono inspections of apartments in NYCHA housing, often in collaboration with Little Sisters of
the Assumption Family Health Services (LSAFHS), a faith-based non-governmental
organization (NGO) whose staff conduct nursing and environmental interventions for East
Harlem residents with asthma living in low-income housing. In 1997, based on lessons learned
in practice, this author developed the Asthma Intervention Methods (AIM) Exposure
Recognition and Reduction Guidelines.15 This initiative was subsequently funded by the NYS
Assembly for $2,000,000, which was distributed to our colleagues at LSAFHS, Mount Sinai
School of Medicine, Queens College, and other not-for-profits. The AIM Program formed a
procedural template for the environmental intervention work that is ongoing to this day by
LSAFHS, whose staff played and continue to play a major role in supporting the interests of the
plaintiffs in the Baez case.
The strong bonds of friendship and collaboration that Microecologies formed with LSAFHS
through our community service work over the years resulted in our being recommended by
LSAFHS and the NRDC to serve as the mold experts to the Special Master in the Baez case. In
that capacity, for the past two years Microecologies, in collaboration with NYCHA management
and building maintenance staff, has developed comprehensive sets of procedures and innovative
methods for the assessment of water damage and mold growth conditions, for the evaluation of
9

the root cause(s) of the excessive moisture conditions, and for the remediation of those
conditions. The firm has also assisted in the design of a case-control (intervention and nonintervention) study that is assessing the effectiveness of these procedures and methods that are
scheduled for NYCHA-wide roll out in early 2019. The evidence-based policy changes that we
have helped NYCHA to develop and implement are expected to result in improved health
outcomes for NYCHA residents suffering from asthma and are a good example of how lessons
learned in practice can be effectively operationalized into changes in best practices and policy.
The NIEHS Translational Research Framework
Researchers at the National Institute of Environmental Health Sciences (NIEHS) have stated that
“a rich history of translational research supported by NIEHS has improved the health of the
American public by demonstrating environmental etiologies for human disease and by
implementing public policy and interventions that reduce disease prevalence.”16, and the NIEHS
has developed a multi-level conceptual framework for translational research.17
Figure 1. NIEHS Translational Research Framework
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Translational Environmental Research Framework (TERF)
The NIEHS framework, and discussions of translational research by other authors16,18 follows the
general perception that research informs practice. However, the NIEHS acknowledges that the
nodes within the rings of their Translational Research Framework are adaptable to research
activities specific to other fields. The Translational Environmental Research Framework
(Figure 2) that we developed has been adapted to recognize that lessons learned from
environmental practice can also be a powerful engine that drives improved health outcomes at
both the individual and population levels by changing best practices, policies and laws, and by
informing research questions that need to be answered by new research studies. This engine is
fueled by close collaboration with colleagues from the clinical, academic/research and NGO
communities and government agencies.
It would be fair to say that in a very real sense the 4000+ investigations conducted in
Microecologies’ environmental practice in response to D/M conditions, and where air sampling
for mold was conducted, could be considered an iterative series of natural experiments. A natural
experiment is a form of research defined as “an empirical study in which individuals (or clusters
of individuals) exposed to the experimental and control conditions are determined by nature or
by other factors outside the control of the investigators, but the process governing the exposures
arguably resembles random assignment. …Natural experiments are most useful when there has
been a clearly defined exposure involving a well-defined subpopulation (and the absence of
exposure in a similar subpopulation) such that changes in outcomes may be plausibly attributed
to the exposure.”19,20,21
Figure 2. Translational Environmental Research Framework (TERF)
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How TERF Informs Our Public Health Initiatives Research Questions and Hypotheses
Retrospectively, it is realized that the TERF framework has driven the AIM and NYCHA
initiatives discussed earlier in this paper in addition to a number of our collaborative initiatives
that have resulted in changes to best practices, policy and law and are ongoing engines that will
continue to drive improvements in public health outcomes, including: 1) 2014 enactment of a
change to the NYC Building Code (Local Law 13) that prohibits the use of paper-faced gypsum
board (aka sheetrock - the paper covering of which promotes Stachybotrys, Penicillium,
Aspergillus and other genera of mold growth when wet) in areas of buildings likely to sustain
water damage and consequential mold growth (including basements and bathrooms), the final
version of the code change that this author wrote and presented at the 2007 International Code
Conference - collaborators: WE ACT for Environmental Justice, Northern Manhattan
Improvement Corporation, US Green Building Council, Staten Island Borough President’s
Office, NYC Mayor’s Office; 2) 2013 publication of NIEHS Disaster Recovery – Mold
Remediation Guidance document based on lessons learned from Superstorm Sandy where
Microecologies conducted inspections of over 500 homes that sustained flood damage collaborators: NIEHS (through collaboration with Jonathan Rosen - author), CUNY (through
collaboration with Jack Caravanos), NYC Resilience, Local Initiative Support Corporation, and;
3) 2006 adoption by WHO of a video entitled Mold Cleanup Guidance for New Orleans Area
Residents Affected by Hurricane Katrina22 based on lessons learned in post-Katrina New Orleans
where the team spent six months inspecting homes and conducting seminars for affected
residents - collaborators: LSAFHS, National Center for Healthy Housing (NCHH), Mount Sinai
School of Medicine.
Prospectively, it is recognized that operationalizing the TERF framework requires continually
fortifying and broadening the collaborations that enable the development and success of new
initiatives. Each of the three studies that form the core of this dissertation have been enabled
and/or enhanced through the careful expansion of this network of collaborators, and lessons
learned from the 4000+ natural experiments conducted in Microecologies’ practice, where air
samples for mold were collected, have informed the research questions and driven the
hypothesis-building processes for each of these studies. The research questions that the first two
studies in this dissertation are intended to help answer are proposed in Mendell’s 2015 Research
Agenda paper: 1) “What are the best currently reported quantified microbiological measurements
for indicating increased health risks (in a dose-related manner if possible) that could be used in
health-protective guidelines for indoor D/M?... The current evidence has not been systematically
mined for this information.”, and 2) “What standard for combined multi-level D/M (indices) can
be constructed, from combinations or expansions of the most strongly health-related D/M (or
microbiologic) assessments in current studies, using information easily collected in a building,
that have potential for dose-related associations with key health effects that are even stronger
than current metrics, and that could be compared in future studies?”7 Environmental practitioners
routinely use results of air sampling for mold to help inform the health protective advice
12

provided to clients, and therefore the importance and usefulness of conducting research that
would help answer these two questions is clearly apparent. It is hypothesized that the systematic
review (Article 1) will find that the current body of scientific evidence does support the
conclusion that there is a significant association between exposure to elevated levels of specific
genera of mold in the indoor air and adverse respiratory health outcomes, and that the nested
case-control study (Article 2) will find that there is a determinable dose-response based
quantitative level that can be expressed in fungal structures per cubic meter for specific genera of
indoor airborne mold above which there is a significant respiratory health risk to atopic
occupants. The research question for the concordance study (Article 3) “Are mold allergies
being under-diagnosed as a result of a misalignment between the predominant genera and species
of mold found in the indoor air of D/M homes and the genus and species-specific mold antigen
extracts used by physicians in the diagnosis of mold allergies?”, is based on the many requests
from clients to review their clinical allergy test results (the equivalent of biological exposure
indices in industrial hygiene), which uniformly show that only a very few of the species of molds
that are routinely found in the indoor air of D/M homes are included in clinical mold allergy
panels. It is hypothesized that the concordance study will find that mold allergies are being
under-diagnosed by physicians as a consequence of this misalignment or discordance, resulting
in the under-recognition of the need for environmental assessments and interventions that could
improve patient health outcomes.
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Supplemental Data S1. Examining the Role of Allostatic Load as a Biochemical
Contributor to the Asthma Epidemic in Low-Income Housing
Studies have found that the risk of atopy and asthma increases by a factor of two to three when
one parent or sibling has asthma and by a factor of three or higher when both parents have
asthma23-25. Atopy, as it relates to asthma is generally defined as the increased predisposition to
produce IgE antibodies in response to exposure to the protein components of aero-allergens (eg.
mold, pollen, roach, mite, and feather).26 Most often this happens in childhood or adolescence.
However, a growing body of research is also consistently finding evidence of association
between maternal, fetal, childhood and adolescent exposure to trauma, traumatic events and
other adverse social factors, considered collectively as allostatic load, and increased risk of atopy
and asthma. These findings have led researchers to conclude that experiencing trauma and interpersonal violence (eg. child abuse, intimate partner violence, community violence), which is
significantly more common among low-income, urban, minority women, may help to explain the
increased risk of asthma found in these communities27,28,29. The biological mechanisms
underlying this increased risk have been studied and are known to involve the dysregulation of
the hypothalamic-pituitary-adrenal (HPA) axis, with the primary aberration being increased
levels of the cortisol hormone which influences the immune systems response to allergens
toward Th2 cell (IgE signaling cell) predominance, which in the prenatal model overcomes the
ability of the enzyme 11 beta hydroxysteroid dehydrogenase type 2 (HSD11B2) to partially
protect the fetus from the transfer of cortisol and other glucocorticoids from the mother to the
fetus27,30.
The literature also suggests that the dysregulation of the HPA axis is further mediated through an
epigenetic change caused by stress/trauma, where there are decreased levels of glucocorticoid
receptors in the hippocampus caused by increased cytosine methylation (inactivation) of the
glucocorticoid receptor gene (NR3C1)31. The glucocorticoid receptors in the hippocampus
perform a critical function in regulating the HPA axis at the hypothalamus through an inhibitory
feedback mechanism when excess glucocorticoid levels in the blood are detected by its receptors.
When glucocorticoid receptors in the hippocampus are inactivated, the negative feedback to the
hypothalamus is inhibited, interfering with the termination of the stress response and allowing
glucocorticoid levels to rise.31,32
In what appears to be a separate epigenetically driven pathway, researchers have also
demonstrated in animal models that DNA methylation at the genes regulating Th differentiation
toward Th2 predominance can result from environmental exposure to inhaled diesel fumes and
by intranasal exposure to Aspergillus fumigatus. The hypermethylation (downregulation) at the
CpG-45, CpG-53 and CpG-205 sites of the Interferon (IFN) gamma promoter (produced by Th1)
and hypomethylation (upregulation) at CpG-408 of the IL-4 promoter (produced by Th2) was
associated with increases in serum IgE levels, the hallmark of atopy33,34.
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Epigenetic changes, while they do not affect DNA, are nonetheless known to be heritable for two
to three generations, and given the ongoing sociological and educational barriers that reduce the
potential for upward mobility among low-income family members resulting in multi-generational
geographic clustering, it is reasonable to suspect that these epigenetic changes in susceptibility to
atopy and asthma may play a role in the continuing high prevalence of asthma in low-income
communities34-37.
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ABSTRACT
Background: Asthma is a major health problem in developed countries throughout the world and
disproportionately affects occupants of low-income housing. Studies have concluded that exposure
to indoor dampness and mold (D/M) contributes significantly to asthma incidence in atopic children
and adults, but unlike other hazardous substances where the primary route of exposure is inhalation,
establishing dose-response based quantitative risk levels for airborne mold has proven elusive.
Objectives: Identify studies that assessed the associations between residential exposure to elevated
levels of airborne mold and adverse respiratory health outcomes. For studies that meet our primary
and secondary inclusion criteria, assess the homogeneity of the findings and examine the criteria
used by the researchers in each study to define elevated levels.
Methods: A literature search was conducted by reviewing the references of prior systematic reviews
and meta-analyses, supplemented by a PubMed Search. The abstracts of articles where the titles
suggested indoor air samples for mold were taken and the associations of interest were assessed to
determine if these primary inclusion criteria were met. Studies that met these criteria were carefully
read to determine if exposure to elevated levels of mold was defined by a numeric value/cut-point or
by a comparison of means or percentiles when assigning participants to the exposed or not
exposed/referent groups, if the associations were assessed by genus/genera, if the health outcome
was asthma or other qualifying respiratory health outcome, and if susceptibility bias had been
accounted for. Studies that met these secondary inclusion criteria were further reviewed to assess the
sampling methods, quantitative criteria used to define elevated indoor airborne mold levels, and the
reported strengths of association found between exposure to elevated indoor airborne mold levels
and adverse respiratory health effects.
Results: 32 studies met our primary inclusion criteria, and 21 of these met both our primary and
secondary inclusion criteria. Of these 21 studies, 20 found a statistically significant association
between exposure to elevated levels of indoor airborne mold and asthma or other health outcomes,
irrespective of the wide range of criteria used to define elevated levels. In all but three studies, the
criteria used by researchers to define elevated levels are inconsistent with the methods prescribed by
the AIHA to be followed by environmental practitioners, which require a comparison of indoor to
outdoor levels. Penicillium was the genus most frequently associated with adverse outcomes (10 of
21), followed by Cladosporium (5 of 21), Alternaria (3 of 21), and Aspergillus (2 of 21).
Conclusions: Based on these results, we conclude that current scientific evidence does support
measuring indoor airborne mold levels as a tool together with other findings in assessing respiratory
health risk to atopic occupants of D/M homes, validating the practices of indoor environmental
consultants. However, to achieve the long elusive goal of establishing dose-response based
quantitative health guidance values for indoor airborne mold, researchers will need to design their
studies such that the results can be translated into practice and policy.
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Introduction
Over 24 million Americans or 7.8% of the U.S. population suffer from current asthma (defined as
having suffered an asthma episode within the last 12 months), and over 6 million or 8.4% of
American children suffer from current asthma, making asthma the leading chronic disease among
children in America.1 A 2010 study conducted by researchers at Mount Sinai School of Medicine
found that the prevalence of childhood asthma in NYC public housing, managed by the NYC
Housing Authority (NYCHA), was 21.8%, three to four times higher than in private family
dwellings and two times higher than in other types of apartment dwellings.2 In NYCHA housing,
where over 400,000 low-income people reside, water damage and excessive moisture problems that
result in mold growth and consequential resident exposure are so pervasive that in 2013, the Natural
Resources Defense Council (NRDC) and other public interest attorneys filed a lawsuit against
NYCHA on behalf of residents suffering from asthma. The suit was successful in requiring NYCHA
to improve its response to the chronic excessive moisture and mold problems considered to be a
major driver of the excess asthma prevalence among NYCHA residents.3
Three major systematic reviews (IOM 20044, WHO 20095, Mendell et al. 20116) have concluded
that there is “sufficient evidence of an association” between exposure to dampness in indoor
environments and a significantly increased risk of asthma, cough, wheeze and upper respiratory
symptoms. The WHO has defined the markers of dampness as visible mold, visible or history of
water damage, visible or measurable excessive moisture and/or a musty odor.5 A 2015 systematic
review by Kanchongkittiphon et al. concluded that current evidence indicates a “causal association”
between exposure to dampness-related agents and exacerbation of asthma in children.7 While a
strong association between exposure to dampness and mold (D/M) and asthma and other respiratory
ailments has now been well established, the authors of the Institute of Medicine (IOM) and World
Health Organization (WHO) systematic reviews found that there was insufficient evidence on which
to base quantitative values for mold levels that would present a respiratory health risk to atopic
occupants, and the authoritative and widely cited 2011 systematic review conducted by Mendell et
al. (479 citations) took this consensus even further by concluding that “current evidence does not
support measuring specific indoor microbiologic factors to guide health-protective actions.”6
However, Mendell recognizes the need for further research, and in 2015 published his
recommendations A Research Agenda on Assessing and Remediating Home Dampness and Mold to
Reduce Dampness-Related Health Effects (supported by the U.S. Department of Housing and Urban
Development) which poses a series of research questions that need to be answered by new and
rigorously designed studies that will contribute to the development of quantitative health guidance
values (HGV’s) for dampness and mold (D/M). One of these research questions, “What are the best
currently reported quantified microbiological measurements for indicating increased health risks (in
a dose-related manner if possible) that could be used in health-protective guidelines for indoor
D/M?... The current evidence has not been systematically mined for this information…” 8 is
essentially an invitation to researchers to scientific consensus.
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In response to this challenge, we conducted a systematic review of peer-reviewed studies to answer
the research question "in the current body of scientific evidence that examined the associations
between occupant exposure to the elevated levels of mold in the indoor of air homes subset of
specific microbiologic factors and the risk of adverse respiratory health outcomes, have researchers
consistently found significant associations?" For each study that met our inclusion criteria, we also
examined the quantitative basis used by the researchers to define elevated levels to answer the
research question, “Does the current body of scientific evidence provide a basis for the establishment
of quantitative health guidance values for mold in the indoor air of homes?”
We hypothesized that the preponderance of studies that met our inclusion criteria would find
significant associations, which would serve to validate the current practices of indoor environmental
practitioners, who routinely perform indoor air sampling for mold as an integral component of water
damage and mold assessments conducted in response to occupant concerns and for post-remediation
verification and use the associated laboratory results together with other findings to guide
recommendations for health-protective actions.9,10 However, the absence of authoritatively
established quantitative risk levels leaves the decision making task of assessing risk up to the
professional judgement of the individual environmental practitioner, which has led to inconsistent
interpretations of laboratory results, undermining their credibility in the eyes of clients, fellow
practitioners, physicians and the courts.
Methods
This systematic review has been structured such that it substantially complies with the requirements
of the Preferred Reporting Items for Systematic Reviews and Meta Analyses (PRISMA – Figure
1).11,12
Other authors of systematic reviews and meta-analyses have conducted extensive literature searches
using multiple databases to identify studies that examined the associations between occupant
exposure to mold and asthma and other adverse respiratory health outcomes. The three prominent
systematic reviews mentioned in the introduction section of this article (IOM 20044, WHO 20095,
Mendell et al. 20116) along with seven additional systematic reviews or meta-analyses evaluating the
associations between exposure to mold and adverse respiratory health effects had been archived in
the files of the authors of this article. To locate other relevant systematic reviews and meta-analyses,
we conducted a literature search (inclusive through 2017) using the PubMed database and entering
the search terms: systematic review OR meta-analysis OR review AND mold OR fungi AND asthma
OR wheeze OR respiratory OR allergic rhinitis OR hypersensitivity pneumonitis. The retrieved
articles were screened by title and then by abstract to determine if the systematic review and/or
meta-analysis evaluated the associations of interest between exposure to airborne mold and asthma
and other adverse respiratory health outcomes.
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Figure 1. PRISMA Checklist for Systematic Reviews
Section/topic

# Checklist item

Reported
on page #

TITLE
Title

1

Identify the report as a systematic review, meta-analysis, or both.
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2

Provide a structured summary including, as applicable: background;
objectives; data sources; study eligibility criteria, participants, and
interventions; study appraisal and synthesis methods; results;
limitations; conclusions and implications of key findings; systematic
review registration number.

20

Rationale

3

Describe the rationale for the review in the context of what is already
known.

21

Objectives

4

Provide an explicit statement of questions being addressed with
reference to participants, interventions, comparisons, outcomes, and
study design (PICOS).

22

Protocol and
registration

5

Indicate if a review protocol exists, if and where it can be accessed
(e.g., Web address), and, if available, provide registration information
including registration number.

Not
available

Eligibility
criteria

6

Specify study characteristics (e.g., PICOS, length of follow-up) and
report characteristics (e.g., years considered, language, publication
status) used as criteria for eligibility, giving rationale.

21, 25

Information
sources

7

Describe all information sources (e.g., databases with dates of
coverage, contact with study authors to identify additional studies) in
the search and date last searched.

21, 25

Search

8

Present full electronic search strategy for at least one database,
including any limits used, such that it could be repeated.

21, 25

Study selection

9

State the process for selecting studies (i.e., screening, eligibility,
included in systematic review, and, if applicable, included in the
meta-analysis).

21, 25

Data collection
process

10

Describe method of data extraction from reports (e.g., piloted forms,
independently, in duplicate) and any processes for obtaining and
confirming data from investigators.

21, 25

Data items

11

List and define all variables for which data were sought (e.g., PICOS,
funding sources) and any assumptions and simplifications made.

21, 25

Risk of bias in
individual
studies

12

Describe methods used for assessing risk of bias of individual
studies (including specification of whether this was done at the study
or outcome level), and how this information is to be used in any data
synthesis.

25

Summary
measures

13

State the principal summary measures (e.g., risk ratio, difference in
means).

25

Synthesis of
results

14

Describe the methods of handling data and combining results of
studies, if done, including measures of consistency (e.g., I2) for each
meta-analysis.

See
checklist
#20

ABSTRACT
Structured
summary

INTRODUCTION

METHODS

23

Section/topic

# Checklist item

Reported on
page #

Risk of bias
across studies

15

Specify any assessment of risk of bias that may affect the
cumulative evidence (e.g., publication bias, selective reporting
within studies).

25, see
checklist #19

Additional
analyses

16

Describe methods of additional analyses (e.g., sensitivity or
subgroup analyses, meta-regression), if done, indicating which
were pre-specified.

See checklist
#20

Study selection

17

Give numbers of studies screened, assessed for eligibility, and
included in the review, with reasons for exclusions at each
stage, ideally with a flow diagram.
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Study
characteristics

18

For each study, present characteristics for which data were
extracted (e.g., study size, PICOS, follow-up period) and
provide the citations.

Risk of bias within
studies

19

Present data on risk of bias of each study and, if available, any
outcome level assessment (see item 12).

Results of
individual studies

20

For all outcomes considered (benefits or harms), present, for
each study: (a) simple summary data for each intervention
group (b) effect estimates and confidence intervals, ideally
with a forest plot.

Synthesis of
results

21

Present results of each meta-analysis done, including
confidence intervals and measures of consistency.

Not applicable

Risk of bias
across studies

22

Present results of any assessment of risk of bias across
studies (see Item 15).

29-34, see
checklist #25

Additional analysis

23

Give results of additional analyses, if done (e.g., sensitivity or
subgroup analyses, meta-regression [see Item 16]).

Table 3
35-37

Summary of
evidence

24

Summarize the main findings including the strength of
evidence for each main outcome; consider their relevance to
key groups (e.g., healthcare providers, users, and policy
makers).

See checklist
#20
39, 43

Limitations

25

Discuss limitations at study and outcome level (e.g., risk of
bias), and at review-level (e.g., incomplete retrieval of
identified research, reporting bias).

Conclusions

26

Provide a general interpretation of the results in the context of
other evidence, and implications for future research.

27

Describe sources of funding for the systematic review and
other support (e.g., supply of data); role of funders for the
systematic review.

RESULTS

Table 2
29-34
29-34, see
checklist #25
Table 3
35-37, 38

DISCUSSION

42, 43

See checklist
#2

FUNDING
Funding

43

From: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews
and Meta-Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed1000097

The reference lists of archived and retrieved systematic reviews and meta-analyses found to have
evaluated the associations of interest were then screened by title to identify observational studies that
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suggested our primary inclusion criteria: 1) indoor air samples for mold had been taken from
residences, and; 2) associations between airborne mold levels and respiratory health outcomes were
assessed, were met. The abstracts of these articles were then read to determine if the articles did
meet our primary inclusion criteria and that the health outcomes of interest were presented as odds
ratios, relative risks, hazard ratios or P values.
A full review of the studies/articles meeting our primary inclusion criteria was then conducted (by
two or more of our authors) to determine whether the study was found to meet our secondary
inclusion criteria: 1) exposure to elevated levels of airborne mold being defined as a numeric
value/cut-point or comparison of means or percentiles for defining the exposed vs not
exposed/referent groups; 2) exposure to elevated levels of airborne mold being assessed by genus or
genus and species (for culture sampling) or by genus or genera (for sporetrap sampling) and not by
total fungal counts; 3) the health outcome(s) of interest being asthma, allergic rhinitis, wheeze,
hypersensitivity pneumonitis, other respiratory conditions, emergency room/hospital visits, and/or
allergic sensitization; 4) susceptibility bias having been adequately accounted for (ie. that an effort
was made, generally by allergy testing or participant/family history, to assure that study participants
exposed to elevated levels of airborne mold were unlikely to be susceptible to the respiratory health
outcomes of interest (Note: studies where measures of effect were significant despite not having
accounted for susceptibility bias were considered to meet this criteria – see Discussion section).
To identify additional research studies meeting our inclusion criteria that were more recent than
those cited in the references of the most recent systematic review and/or meta-analysis (Mendell
2015), a second keyword search was conducted using the PubMed database and entering the search
terms: mold OR fungi AND air sampling OR air testing OR spores OR colony forming units OR
elevated levels OR airborne AND asthma OR wheeze OR respiratory OR allergic rhinitis OR
hypersensitivity pneumonitis for the years 2014-2017. The returned articles were then screened by
title to identify observational studies that suggested our primary inclusion criteria were met. The
abstracts of these articles were then read to determine if the article did meet our primary inclusion
criteria and that the health outcomes of interest were presented as odds ratios, relative risks, hazard
ratios or P values. A full review of the identified articles was then conducted to determine if the
articles met our secondary inclusion criteria, as defined in the paragraph above.
The research studies found to meet both our primary and secondary inclusion criteria identified from
either our search of the references in the archived and retrieved systematic reviews and metaanalyses or from our PubMed search were further reviewed to assess the sampling methods,
quantitative criteria used to define elevated indoor airborne mold levels, and the strengths of
association found between exposure to elevated levels of airborne mold and adverse respiratory
health effects.
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To assess the potential effect that log-normalizing exposure data may have on the reported strengths
of association, the studies found to meet both our primary and secondary inclusion criteria were
divided between studies that log-normalized exposure data and studies that did not.
Results
Our keyword search to identify systematic reviews and/or meta-analyses evaluating the associations
between quantitatively assessed exposure to mold and increased risk of asthma or other adverse
respiratory health outcomes yielded 202 articles. Six of these articles had been previously archived
and 177 articles were excluded based on our review of the article title. The abstracts of the remaining
19 articles were reviewed and only one was found to have assessed the associations of interest. The
remaining article (Sharpe 2014) was added to the 10 previously archived systematic reviews and/or
meta-analyses (see Table 1). The reference lists of these 11 systematic reviews and/or meta-analyses
were reviewed by title and a total of 221 studies/articles published between 1989 and 2014 were
identified that suggested our primary inclusion criteria may have been met. We then reviewed the
abstracts of these 221 articles, and identified a total of 27 studies that did meet our primary inclusion
criteria. A full review of these 27 articles was then conducted to determine whether the study was
found to meet our secondary inclusion criteria. A total of 17 studies were found to meet these
secondary inclusion criteria.
Our keyword search to identify additional research studies/articles meeting our primary inclusion
criteria that were more recent than those cited in the references of Mendell 20158 yielded 260
studies/articles published between 2014 and 2017. These articles were reviewed by title and a total
of 49 articles were identified that suggested our primary inclusion criteria were met. We then
reviewed the abstracts of these 49 articles, and identified a total of five articles that did meet our
primary inclusion criteria, bringing the total number of articles found to meet our primary inclusion
criteria to 32 (Table 2). A full review of the five articles published between 2014 and 2017 that met
our primary inclusion criteria was then conducted to determine whether the study was found to meet
our secondary inclusion criteria. Four of these studies were found to meet these criteria, bringing the
total number of studies found to meet our secondary inclusion criteria to 21 (Table 3).
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Figure 2. Process Flow Diagram of Systematic Search and Included Studies
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Table 1. Systematic review/meta-analyses studies from authors’ archived files and 2017 keyword search
from which primary research studies were reviewed for eligibility and selected for inclusion.

2004

IOM4

64

Studies With
Abstracts Indicating
Article Met Primary
Inclusion Criteria
(Table 2)
11

2007

Fisk13

11

1

1

2009

WHO5

22

5

4

2011

Mendell6

31

0

0

2012

Quansah14

20

1

1

2013

Jaakkola15

25

0

0

2014

Mendell8

6

2

1

2014

Sharpe17

18

4

1

2015

Patelarou18

6

1

0

2015

Kanchongkittiphon7

9

1

1

2015

Mendell8

9

1

2

221

27

17

49

5

4

Institution or
Year
Lead Author

Total

2017

PubMed Search

Studies With Titles
Suggesting that
Article Met Primary
Inclusion Criteria

Studies That Met
Primary and
Secondary
Inclusion Criteria
(Table 3)
6
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Table 2. Secondary inclusion criteria review and summary for the 32 studies that met primary inclusion criteria
Checkmarks = Yes; Blanks = No

Year

Investigator

Country, Study Population &
Health Outcome of Interest

Elevated Levels of
Assessed
Indoor
Airborne Mold
by Genus/
Meets Secondary
Genera**
Inclusion Criteria
Outdoor
levels

1989

Platt et al.19

Scotland/England,
Children (n = 1169),
Respiratory & other symptoms

Log
Norm.
Expos.
Data*

Susceptibility
Accounted
for

Meets All
Inclusion
Criteria

Referent
group

✓

Reviewed 3/21/18 by WMS & 5/20/18 by WMS and NK. Review confirms that primary inclusion criteria were met. Air sample results
analyzed for total spore counts only. Total spore counts were divided into low, medium and high with low serving as the referent group.
Parents were administered a questionnaire with housing and health questions, but data presented does not suggest questions concerning
family history or other measures of susceptibility were considered.
1989

Waegemaeker
et al.20

Netherlands, Children
(n = 56 with air samples),
Cough, wheeze, SOB & asthma

✓

✓

Reviewed 6/9/18 by WMS and NK. Review suggests that primary inclusion criteria may have been met. Air sample results analyzed for
total spore counts only. P values (>0.05) found for cough and combination of symptoms with log-normalized increases in total indoor
airborne mold. Data presented does not suggest that susceptibility criteria were met.
1990

Strachan et
al.21

Scotland, Children (n = 88),
Wheeze

✓

✓

Reviewed 3/21/18 by WMS & 6/9/18 by WMS and NK. Review confirms that primary inclusion criteria were met. Review finds that
exposure data for indoor airborne mold by genus were log-normalized for assessing associations with wheeze. Data presented does not
suggest that susceptibility criteria were met (27 of 88 children had prior history of wheeze; study method is population survey and
conclusion refers to risk of wheeze among children in general population).
1998

Etzel et al.22

U.S.A., Infants (n = 40),
Pulmonary hemorrhage

✓

✓

✓

N/A

Reviewed 3/22/18 by WMS & 6/9/18 by WMS and NK. Review confirms that primary inclusion criteria were met. Air sample results
analyzed by genus. Odds ratio (OR) based on increased risk of pulmonary hemorrhage (hemosiderosis) with an increase of 10 CFU/m 3 in
mean concentration of Stachybotrys atra. Because this outcome is considered a toxic rather than an allergic response, susceptibility criteria
are not applicable.
1998

Garrett et al.23

Australia, Children (n = 148),
Asthma

✓

✓

✓

✓

✓

Reviewed 3/21/18 by WMS & 6/4/18 by WMS and NK. Review confirms that primary inclusion criteria were met. Air sample results
analyzed by genus. Exposure data was log-normalized. OR based on increased risk of asthma with an increase in indoor airborne mold
levels of Penicillium. Skin prick tests were performed on cases and controls with 31% cases positive to at least 1 fungal extract compared
to 23% of controls, and therefore susceptibility criteria were met.
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Year

Investigator

Country, Study Population &
Health Outcome of Interest

Log
Elevated Levels of
Assessed
Norm.
Indoor
Airborne
Mold
by Genus/
Expos.
Meets Secondary
Genera**
Inclusion Criteria
Data*
Outdoor
levels

2000

Ross et al.24

U.S.A., Asthmatic adults and
children (n = 57), Asthma (five
categories of related events)

✓

Susceptibility
Accounted
for

Meets All
Inclusion
Criteria

✓

✓

Referent
group

✓

✓

Reviewed 3/23/18 by WMS & 5/28/18 by WMS and NK. Review confirms that primary inclusion criteria were met. Air sample results
analyzed by genus. Review finds that exposure data for indoor airborne mold were log-normalized before being dichotomized and assessing
associations with asthma-related events. 53 of 57 participants had asthma and four had signs or symptoms of asthma and therefore
susceptibility criteria were met.
2001

Dharmage
et al.25

Australia, Young Adults
(n = 485), Current asthma

✓

✓

✓

✓

N/A

Reviewed 3/23/18 by WMS & 6/23/18 by WMS and NK. Review confirms that primary inclusion criteria were met. Air sample results
analyzed by genus. Exposure data was log-normalized. Review finds that CFU levels were divided into four quartiles and analyzed by
comparing risk of bronchial hyperreactivity (BHR) between highest and lowest quartiles. Skin prick tests conducted on 480 of 485
participants and family history question asked on questionnaire, but data presented does not suggest susceptibility bias was accounted for in
selection criteria for data analysis; however, despite not accounting for susceptibility bias study found significant increased risk of BHR
between exposure to highest and lowest quartiles of Cladosporium and Penicillium.
2001

Su et al.26

Taiwan, Children (n = 35), Asthma

✓

✓

Reviewed 3/23/18 by WMS & 6/26/18 by WMS and NK. Review confirms that primary inclusion criteria were met. Air sample results were
presented but measures of effect were not reported by genus. Control group was chosen by matching age, gender and proximity of residents
and therefore data presented does not suggest that susceptibility criteria were met.
2002

Gent et al.27

U.S.A., Infants (n = 880),
Wheeze, persistent cough

✓

✓

✓

✓

Reviewed 3/23/18 by WMS & 6/2/18 by WMS and NK. Review confirms that primary inclusion criteria were met. Air sample results
analyzed by genus. Spore counts were divided into undetectable, low, medium and high with undetectable serving as the referent group.
Cohort comprised of infants that had at least one older sibling with physician-diagnosed asthma and therefore susceptibility criteria were met.
2002

Müller et al.28

Germany, Children (n = 200),
Resp. tract infections and Atopy

✓

✓

✓

✓

✓

Reviewed 6/26/18 by WMS and NK. Review confirms that primary inclusion criteria were met. Air sample results analyzed by genus.
Review finds that samples were taken in the child’s room and from outdoors in each home with the outdoor sample serving as the control.
Results were adjusted for atopic family history and therefore susceptibility criteria were met.
2003

Stark et al.29

U.S.A., Children (n = 499),
Lower respiratory illness

✓

✓

✓

✓

✓

Reviewed 3/23/18 by WMS & 5/29/18 by WMS and NK. Review confirms that primary inclusion criteria were met. Air sample results
analyzed by genus. Review finds that exposure data for indoor airborne mold were log-normalized. Relative risk (RR) assessed by comparing
risk of LRI for children exposed to high levels (90th percentile) contrasted to referent group (<90th percentile, although not explicit) of
airborne Penicillium. All participants had a family history of asthma and therefore susceptibility criteria were met.
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Year

Investigator

Country, Study Population &
Health Outcome of Interest

Log
Elevated Levels of
Assessed
Norm.
Indoor
Airborne
Mold
by Genus/
Expos.
Meets Secondary
Genera**
Inclusion Criteria
Data*
Outdoor
levels

2003

Belanger et
al.30

U.S.A., Infants (n = 849) with an
asthmatic sibling,
Wheeze, persistent cough

Susceptibility
Accounted
for

Meets All
Inclusion
Criteria

Referent
group

✓

✓

Reviewed 3/22/18 by WMS & 6/23/18 by WMS and NK. Review confirms that primary inclusion criteria were met. Air sample results
analyzed for total CFU only. Increased risk assessed for increase per 20 CFU of total fungi. Data analyzed separately for mothers with
physician diagnosed asthma and therefore susceptibility criteria were met.
2004

Jovanovic et
al.31

✓

Germany, Children (n = 397),
Allergic history

Reviewed 3/21/18 by WMS & 6/23/18 by WMS and NK. Review confirms that primary inclusion criteria were met. Air sample data
collected by genus; however, reported associations with allergic history appear to be for indoor total airborne mold levels only, which is
inconsistent with statement in abstract citing no difference found in fungi species levels between children with and without allergic history
but data not presented. Data presented does not suggest that susceptibility criteria were met.
2005

Gelincik et al.32

✓

Turkey, Adults (n = 82),
Allergic rhinitis

Reviewed 3/24/18 by WMS & 6/27/18 by WMS and NK. Review confirms that primary inclusion criteria were met. Air sample data
collected by genus; however, reported associations with allergic rhinitis are for total indoor airborne fungal propagules only. Data presented
does not suggest that susceptibility criteria were met.
2005

Matheson et
al.33

Australia, Adults (n = 360),
Current Asthma

✓

✓

✓

✓

✓

Reviewed 3/24/18 by WMS & 6/27/18 by WMS and NK. Review confirms that primary inclusion criteria were met. Air sample data
collected by genus; however, associations were analyzed for Cladosporium only and data was log-normalized. Significant association found
for increased risk of asthma with doubling of indoor airborne Cladosporium exposure levels for same participants, and therefore both
elevated levels and susceptibility criteria were met.
2005

Stark et al.34

U.S.A., Infants and Children
(n = 405), Allergic rhinitis

✓

✓

✓

✓

✓

Reviewed 3/21/18 by WMS & 6/9/18 by WMS and NK. Review confirms that primary inclusion criteria were met. Air sample results
analyzed by genus. Review finds that exposure data for indoor airborne mold were log-normalized before being dichotomized and assessing
associations with allergic rhinitis. At least one parent had history of hay fever, asthma or allergies, and therefore susceptibility criteria were
met.
2006

Turyk et al.35

U.S.A., Children (n = 61), Asthma

✓

✓

✓

✓

Reviewed 3/24/18 by WMS & 6/28/18 by WMS and NK. Review confirms that primary inclusion criteria were met. Air sample results
analyzed by genus. Review finds that CFU levels were divided into tertiles and analyzed by comparing risk of asthma between highest and
lowest tertiles. All children had physician diagnosed asthma, and therefore susceptibility criteria were met.
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Year

Investigator

Country, Study Population &
Health Outcome of Interest

Log
Elevated Levels of
Assessed
Norm.
Indoor
Airborne
Mold
by Genus/
Expos.
Meets Secondary
Genera**
Inclusion Criteria
Data*
Outdoor
levels

2006

Osborne et al.36

U.S.A., Infants (n = 144),
Rhinitis and Allergic sensitization

✓

Susceptibility
Accounted
for

Meets All
Inclusion
Criteria

✓

✓

Referent
group

✓

✓

Reviewed 3/24/18 by WMS & 6/28/18 by WMS and NK. Review confirms that primary inclusion criteria were met. Air sample results
analyzed by genus. P values based on comparing exposure to geometric means of indoor airborne Basidiospores of children with and without
rhinitis, and by comparing exposure to geometric means of indoor airborne Penicillium/Aspergillus of children with and without allergic
sensitization. All children had one parent who tested positive to one of 15 aeroallergens, and therefore susceptibility criteria were met.
2007

Haverinen
et al.37

✓

Finland, School teachers (n = 81),
Cough plus multiple symptoms

✓

Reviewed 3/23/18 by WMS & 6/23/18 by WMS and NK. Review confirms that primary inclusion criteria were met. Air sample results
analyzed for total viable and non-viable fungi only. Review finds that exposure data for indoor airborne mold were log-normalized before
assessing associations with health outcomes of interest. Data presented does not suggest that susceptibility criteria were met.
2009

Bundy et al.38

U.S.A., Asthmatic Children
(n = 225), Airway hyperreactivity

✓

✓

✓

✓

Reviewed 3/22/18 by WMS & 6/23/18 by WMS and NK. Review confirms that primary inclusion criteria were met. Air sample results
analyzed by genus. OR based on increased risk of peak expiratory flow rate variability >18.5% among children exposed to any Penicillium
compared to those exposed to no Penicillium. All participants had physician diagnosed asthma, and therefore susceptibility criteria were met.
2010

Holme et al.39

Sweden, Children (n = 400)
Asthmatic and allergic symptoms

✓

✓

✓

Reviewed 3/22/18 by WMS & 6/23/18 by WMS and NK. Review confirms that primary inclusion criteria were met. Air sample results
analyzed by genus. P values based on increased risk of asthma or allergy symptoms for children exposed to any indoor airborne mold (by
genus) contrasted to children exposed to no indoor airborne mold (by genus). Data presented does not suggest that susceptibility criteria were
met.

2010

U.S.A., Children (n = 467),
Pongracic et Asthma symptom days per 2 weeks
al.40
(MSD), Unscheduled ER or clinic
visits (UV)

✓

✓

✓

✓

✓

✓

Reviewed 7/1/18 by WMS and NK. Review confirms that primary inclusion criteria were met. Air samples results analyzed by genus.
Review finds that indoor and outdoor samples were taken from each home, with the outdoor sample serving as the control. Exposure data
was log-normalized. P value and OR based on increased risk of MSD and UV associated with 10-fold increase in concentration of
Penicillium. All participants had a positive skin test to at least one fungal allergen extract and therefore susceptibility criteria were met.
2010

Rosenbaum
et al.41

U.S.A., Infants (n = 103), Wheeze

✓

✓

✓

✓

Reviewed 7/1/18 by WMS and NK. Review confirms that primary inclusion criteria were met. Air sample results analyzed by genus. Review
finds that CFU levels were divided into undetectable, low, and high with undetectable serving as the referent group. All participants had
maternal history of asthma and therefore susceptibility criteria were met.
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Year

Investigator

Country, Study Population &
Health Outcome of Interest

Elevated Levels of
Assessed
Indoor
Airborne Mold
by Genus/
Meets Secondary
Genera**
Inclusion Criteria
Outdoor
levels

2011

Jones et al.42

U.S.A., Children (n = 99), Asthma

✓

Log
Norm.
Expos.
Data*

Susceptibility
Accounted
for

Meets All
Inclusion
Criteria

✓

✓

✓

Referent
group

✓

Reviewed 7/7/18 by WMS and NK. Review suggests that primary inclusion criteria were met. Air sample results analyzed by genus. Review
finds that exposure data for indoor airborne mold were log-normalized before assessing associations with asthma. Although siblings with
asthma were excluded from the control group, OR’s were adjusted for family history and therefore susceptibility criteria were met.
2011

Sharma et al.43

India, Children (n = 95)
Asthma/allergic rhinitis

✓

Reviewed 3/24/18 by WMS & 6/28/18 by WMS and NK. Review suggests that primary inclusion criteria were met. Air sample results
analyzed by genus. P values based on comparison of indoor to outdoor levels for case homes; however, no similar data presented for control
homes. Data presented does not suggest that susceptibility criteria were met.

2012

Gent et al.44

U.S.A., Children with asthma or
asthma symptoms (n =1,233),
Days of wheeze, cough and high
asthma severity score

✓

✓

✓

✓

✓

Reviewed 3/23/18 by WMS & 5/31/18 by WMS and NK. Review confirms that primary inclusion criteria were met. Air sample results
analyzed by genus. Review finds that exposure data for indoor airborne mold were log-normalized before assessing associations with wheeze,
persistent cough, and higher asthma severity score among children exposed to any Penicillium. Cohort comprised of children with asthma
and/or persistent cough and/or use of rescue medication for asthma and therefore susceptibility criteria were met.
2012

Meng et al.45

U.S.A., Children (n = 173),
Asthma

✓

✓

✓

✓

✓

N/A

Reviewed 7/1/18 by WMS and NK. Review confirms that primary inclusion criteria were met. Air sample results analyzed by genus. Review
finds that indoor and outdoor samples were taken from each home, with the outdoor sample serving as the control. Exposure data for indoor
airborne mold were log-normalized before assessing frequencies and levels of exposure to indoor airborne mold in the homes of asthmatic
children compared to control homes with no asthmatic children. Data presented does not suggest that susceptibility criteria were met, but
nonetheless statistically significant P values were found for several genera.
2015

Behbod et al.46

U.S.A., Children (n = 408),
Wheeze, Asthma, and Fungal
Sensitization

✓

✓

✓

✓

✓

Reviewed 7/4/18 by WMS and NK. Review confirms that primary inclusion criteria were met. Air sample results analyzed by genus. Review
finds that exposure data for indoor airborne mold were log-normalized before assessing risk of wheeze, asthma and fungal sensitization
between quartiles. All participants had a family history of allergic disease or asthma and therefore susceptibility criteria were met.
2015

Vicendese et
al.47

Australia, Children (n = 44),
Hospital readmission for asthma

✓

✓

✓

✓

Reviewed 7/4/18 by WMS and NK. Review confirms that primary inclusion criteria were met. Air sample results analyzed by genus.
Significant association found for increased risk of hospital readmission for asthma with doubling of indoor airborne Cladosporium levels. All
participants had at least one hospital admission for asthma, and therefore susceptibility criteria were met.
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Year

Investigator

Country, Study Population &
Health Outcome of Interest

Elevated Levels of
Assessed
Indoor
Airborne Mold
by Genus/
Meets Secondary
Genera**
Inclusion Criteria
Outdoor
levels

2016

Arikoglu et al.48

Turkey, Children (n = 61),
Asthma

✓

Log
Norm.
Expos.
Data*

Susceptibility
Accounted
for

Meets All
Inclusion
Criteria

✓

✓

Referent
group

✓

Reviewed 7/4/18 by WMS and NK. Review confirms that primary inclusion criteria were met. Air sample results analyzed by genus.
Significant association found for increased risk of asthma among children exposed to elevated levels of indoor airborne Cladosporium. All
participants were diagnosed with allergic respiratory conditions and therefore susceptibility criteria were met.
2016

Huang et al.49

✓

China, Children (n = 454),
Asthma

✓

Reviewed 7/4/18 by WMS and NK. Review confirms that primary inclusion criteria were met. Air sample results analyzed for total spore
counts only. Risk of asthma assessed by comparing exposure to total levels of indoor airborne mold between cases and controls. Data presented
suggests that susceptibility criteria were met.
2017

Polyzoi et al.50

Canada, Children (n = 715),
Asthma and Persistent Cold

✓

✓

✓

✓

N/A

Reviewed 7/7/18 by WMS and NK. Review confirms that primary inclusion criteria were met. Air sample results analyzed by genus. Review
finds that exposure data for indoor airborne mold were log-normalized before assessing risk of asthma and persistent cold between quartiles.
Data presented does not suggest that susceptibility criteria were met (family history data collected but apparently not used in calculations), but
nonetheless statistically significant P values were found. (Note: E. Polyzoi et al 2017 study appears to be a continuation of D. Polyzois et al
2016 study with relevant findings being identical)

*Log normalized exposure data
**Measure of effect between exposure to elevated levels of airborne mold and health outcome was reported by
genus or genera (Penicillium/Aspergillus).
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Table 3. Summary Data for 21 Studies that Met Primary and Secondary Inclusion Criteria

Year

Investigator

Sampling
Method/
No. Events

Study Design/Population and
Health Outcomes

Findings
Exposure to Elevated Levels of:

Strength of
Association

Studies That Did Not Log-Normalize Exposure Data
1998

Etzel, et al.22

Culture/
Single

Case-control (n=40) of infants (U.S.A.)
Health Outcome - Pulmonary Hemorrhage

Stachybotrys atra - Pulmonary
hemorrhage (OR 9.83, 95% CI 1.08 3 x 106)

Statistically
significant

Definition of Elevated Indoor Airborne Mold Levels for Assignment to Exposed Group- OR based on increased risk of pulmonary hemorrhage
(hemosiderosis) with an increase of 10 CFU/m3 in mean concentration of Stachybotrys atra.
2002

Gent, et al.27

Culture/
Single

Prospective cohort (n=880) of infants (U.S.A.)
with 1+ sibling with asthma
Health Outcomes - Wheeze and Cough

Penicillium - Wheeze (RR 2.15, 95%
CI, 1.34-3.46) Cough (RR 2.06, 95%
CI, 1.31-3.24)

Statistically
significant

Definition of Elevated Indoor Airborne Mold Levels for Assignment to Exposed Group- RR’s based on contrasting health outcomes of
infants exposed to CEC exposure categories - high (≥ 1,000 CFU/m3) versus 0 (undetectable) levels of Penicillium.
2002

Müller, et al.28

Culture/
Single

Prospective cohort (n=200) of children (Germany)
Health Outcomes – Respiratory tract infections
and Atopy

Penicillium – Resp. tract infections
(OR 6.88, 95% CI 1.21-38.9)
Aspergillus – Atopy (p < 0.05)

Statistically
significant

Definition of Elevated Indoor Airborne Mold Levels for Assignment to Exposed Group- OR based on increased risk of respiratory tract infection for
children exposed to Penicillium > 100 CFU/m3 higher than outdoor levels. P value based on increased risk of atopy (suppression of Th1 cytokines INF-γ,
TNF-α and IL-2) for children exposed to Aspergillus (authors hypothesize due to mycotoxins) prejudicing immune response towards Th2/IgE pathway.
2006

Turyk, et al.35

Culture/
Single

Cross sectional (n=61) of children (U.S.A.)
Health Outcome - Asthma

Penicillium – Asthma (OR 4.9, 95% CI
1.2-20.2)

Statistically
significant

Definition of Elevated Indoor Airborne Mold Levels for Assignment to Exposed Group- OR based on increased risk of asthma for children exposed to
highest versus lowest tertiles of Penicillium.

2009

Bundy, et al.38

Culture/
Single

Cross sectional (n=225) of children (U.S.A.)
with asthma
Health Outcome - Airway Hyperreactivity

Penicillium – Airway hyperreactivity
(OR 2.4, 95% CI 1.2-4.8)

Statistically
significant

Definition of Elevated Indoor Airborne Mold Levels for Assignment to Exposed Group- OR based on contrasting increased risk of mean peak expiratory
flow variability >18.5% (75th percentile) for children exposed to any Penicillium compared to those exposed to no Penicillium.
2010

Rosenbaum, et al.41

Culture/
Single

Prospective cohort (n=103) of infants (U.S.A.),
Health Outcome - Wheeze

Penicillium – Wheeze (OR 6.18, 95%
CI 1.34–28.46)

Statistically
significant

Definition of Elevated Indoor Airborne Mold Levels for Assignment to Exposed Group- OR based on increased risk of wheeze for children in highest
tertile contrasted to lowest tertile (undetected) of exposure to Penicillium.

2015

Vicendese, et al.47

Culture/
Single

Case-control (n=44) of children (Australia)
Health Outcome - Hospital readmission

for asthma

Cladosporium – Hospital
readmission for asthma (OR 1.68,
95% CI 1.04-2.72)

Statistically
significant

Definition of Elevated Indoor Airborne Mold Levels for Assignment to Exposed Group- OR based on increased risk of hospital readmission for asthma
with doubling of Cladosporium levels.
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Year

Investigator

Sampling
Method/
No. Events

2016

Arikoglu, et al.48

Culture/
Multiple

Study Design/Population and
Health Outcomes
Prospective cohort (n=61) of children (Turkey)
Health Outcome - Asthma

Findings
Exposure to Elevated Levels of:

Cladosporium – Asthma (p=0.003)

Strength of
Association

Statistically
significant

Definition of Elevated Indoor Airborne Mold Levels for Assignment to Exposed Group- P value based on increased risk of asthma among children exposed
to elevated levels of Cladosporium levels >176 CFU/m3 (average level in nine 9-hour samples over one year).

Studies That Log-Normalized Exposure Data
1998

Garrett, et al.23

Culture/
Multiple

Case-control (n=148) of children (Australia)
Health Outcome - Asthma

Penicillium - Asthma (OR 1.43, 95%
CI 1.03-2.00)

Statistically
significant

Definition of Elevated Indoor Airborne Mold Levels for Assignment to Exposed Group- OR based on increased risk of asthma with an increase in exposure
to Penicillium by 100 CFU/m3.

2000

Ross, et

al.24

Culture/
Multiple

Prospective cohort (n=57) of asthmatic adults
and children (U.S.A.),
Health Outcome - Asthma (five categories of
related events)

Alternaria – Missing sleep due to
asthma (OR 4.8, 95% CI 1.6-14.6)

Statistically
significant

Definition of Elevated Indoor Airborne Mold Levels for Assignment to Exposed Group- OR based on contrasting health outcome for participants exposed
to higher dichotomized levels of Alternaria contrasted to referent group; however, data presented does not specify basis for dichotomization.

2001

Dharmage, et al.25

Culture/
Single

Case-control (n=485) of young adults (Australia)
Health Outcome - Current Asthma - defined as
wheeze + bronchial hyperreactivity (BHR)

Cladosporium - BHR (OR 8.5, 95% CI
1.6-44.3) Penicillium - BHR (OR 3.9,
95% CI 1.1-14.3)

Statistically
significant

Definition of Elevated Indoor Airborne Mold Levels for Assignment to Exposed Group- OR’s based on increased risk of current asthma (assessed as BHR)
of young adults exposed to highest versus lowest quartiles of Cladosporium and Penicillium.
2003

Stark, et al.29

Culture/
Single

Prospective cohort (n=499) of children (U.S.A.)
Health Outcome - Lower Respiratory Illness

Penicillium - LRI (RR 1.73, 95%
CI, 1.23-2.43)

Statistically
significant

Definition of Elevated Indoor Airborne Mold Levels for Assignment to Exposed Group- RR based on contrasting health outcomes of children exposed to
high levels (>90th percentile) of Pen/Asp and Alternaria contrasted to referent group (appears to be 10th percentile, although not explicit).

2005

Stark, et

al.34

Culture/
Single

Prospective cohort (n = 405) of infants
and children (U.S.A.),
Health Outcome - Allergic rhinitis

Asp. – Rhinitis (HR 1.10, 95% CI
0.43-2.80); Clad. – Rhinitis (HR 1.25,
95% CI 0.43-3.64); Pen. – Rhinitis
(HR 0.69, 95% CI 0.23-2.60)

Not
Statistically
significant

Definition of Elevated Indoor Airborne Mold Levels for Assignment to Exposed Group- HR’s based on increased risk of allergic rhinitis among infants and
children exposed to elevated levels of mold by genus in high fungi group (>90th percentile) contrasted to low fungi group (<90th percentile).

2005

Matheson, et al.33

Culture/
Single

Prospective cohort (n=360) of adults (Australia)
Health Outcome - Current Asthma

Cladosporium – Asthma (OR 1.52,
95% CI 1.08-2.13)

Statistically
significant

Definition of Elevated Indoor Airborne Mold Levels for Assignment to Exposed Group- OR based on increased risk of asthma with doubling of
Cladosporium levels from 1996 to 1998 for same participants.
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Sampling
Year

Investigator

Method/
No. Events

2006

Osborne, et al.36

Sporetrap/
Multiple

Study Design/Population and
Health Outcomes

Nested case-control (n=144) of infants (U.S.A.)
Health Outcomes – Rhinitis and
Allergic sensitization

Findings
Exposure to Elevated Levels of:
Basidiospores – Rhinitis (p < 0.01)
Penicillium/Aspergillus – Allergic
sensitization (p < 0.01)

Strength of
Association

Statistically
significant

Definition of Elevated Indoor Airborne Mold Levels for Assignment to Exposed Group- P values based on increased risk of rhinitis with exposure to
higher level of Basidiospores (GM ~20 spores/m3 versus ~12 spores/m3) and increased risk of allergic sensitization with exposure to higher level of
Penicillium/Aspergillus (GM ~64 spores/m3 versus ~28 spores/m3).

2010

Pongracic, et

al.40

Culture/
Multiple

Prospective cohort (n=467) of children (U.S.A.),
Health Outcomes - Asthma symptom days per 2
weeks (MSD), Unscheduled ER or clinic visits
(UV)

Penicillium - 1.19 MSD per 2 weeks
(p=0.03)
Penicillium - UV (OR 1.15, 95%, CI
1.05-1.27)

Statistically
significant

Definition of Elevated Indoor Airborne Mold Levels for Assignment to Exposed Group- P value and OR based on increased risk of MSD and UV,
respectively, associated with 10-fold increase in concentration of Penicillium, after adjusting for outdoor levels.

2011

Jones, et al.42

Culture/
Single

Nested case-control (n=99) of children (U.S.A.)
Health Outcome - Asthma

Aspergillus - Asthma (OR 6.11, 90%
CI 1.37–27.19)

Statistically
significant

Definition of Elevated Indoor Airborne Mold Levels for Assignment to Exposed Group- OR based on increased risk of asthma for children without a
family history of asthma exposed to elevated levels of Aspergillus.

2012

Gent, et al.44

Culture/
Single

Prospective cohort (n=1,233) of children
(U.S.A.) with asthma
Health Outcomes – Days of Wheeze, Cough, and
High Asthma Severity

Penicillium - Wheeze (OR 2.12, 95%
CI 1.12-4.04), Persistent cough (OR
2.01, 95% CI 1.05-3.85), Asthma
severity score (OR 1.99, 95% CI 1.063.72)

Statistically
significant

Definition of Elevated Indoor Airborne Mold Levels for Assignment to Exposed Group- OR’s based on contrasting health outcomes of children exposed to
any Penicillium to health outcomes of referent group (no Penicillium).

2012

Meng, et al.45

Sporetrap/
Single

Case-control (n=173) of children (U.S.A)
Health Outcome - Asthma

Pen/Asp - Asthma (p<0.04)
Basidiospores and Epicoccum Asthma (p<0.05)

Statistically
significant

Definition of Elevated Indoor Airborne Mold Levels for Assignment to Exposed Group- P values based on increased risk of asthma for children exposed to
higher mean levels of Pen/Asp, Basidiospores and Epicoccum, after adjusting for outdoor levels.

2015

Behbod, et

al.46

Culture/
Single

Prospective cohort (n = 408) of children
(U.S.A.),
Health Outcomes - Wheeze, Asthma, and
Fungal Sensitization

Alternaria – Asthma (HR 1.70, 95%
CI 1.01-2.86)

Statistically
significant

Definition of Elevated Indoor Airborne Mold Levels for Assignment to Exposed Group- HR based on increased risk (in sensitivity analysis) of asthma
development among children exposed to highest quartile (>75th percentile) of Alternaria contrasted to lower three quartiles (<75th percentile.).

2017

Polyzoi, et al.50

Culture/
Multiple

Prospective cohort (n=715) of children (Canada)
Health Outcomes - Asthma and

Persistent Cold

Cladosporium – Asthma and Persistent
Cold (p<0.02)

Statistically
significant

Definition of Elevated Indoor Airborne Mold Levels for Assignment to Exposed Group- P value based on increased risk of asthma and persistent cold
among children exposed to highest quartile (>75th percentile) of Cladosporium contrasted to lowest quartile (<25th percentile).
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Figure 3: Forest Plot of OR’s, RR’s and HR’s and Confidence Intervals for Studies on Table 3

The above forest plot graph (Figure 3) displays the odds ratios, relative risks or hazard ratios
with corresponding confidence intervals for the studies that met both our primary and secondary
inclusion criteria (Table 3). The size of the boxes represents an approximation of the relative
size of the number of participants in each study. The left vertical line represents unity, and the
graph shows that 17 of the 18 studies (Note: 3 studies on Table 3 with significant p values
omitted) reported a significantly increased risk of adverse respiratory health effects with
exposure to elevated levels of mold in the indoor air.
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Discussion
Of the 21 studies described in Table 3 that met both our primary and secondary inclusion criteria, 20
studies found at least one statistically significant association between exposure to elevated levels of
mold in the indoor air and an adverse respiratory health outcome, irrespective of the wide range of
criteria used by researchers to define elevated levels. These results suggest that the current scientific
evidence does support measuring the indoor airborne mold subset of quantitative mold
measurements in assessing potential respiratory health risk to occupants, and validates the practices
of environmental consultants who routinely conduct indoor air sampling for mold as an integral
component of their indoor environmental assessments and use the associated laboratory results as a
tool together with other findings to guide recommendations for health protective actions and to
assess whether clearance has been achieved on mold remediation projects. However, the wide range
of criteria used in these studies to define the quantitative level of airborne mold at which study
participants are assigned to the exposed group does not provide a basis or even a starting point for
the development of quantitative health guidance values (HGV's) for indoor airborne mold.
The absence of authoritative HGV's for indoor airborne mold leaves the decision making task of
assessing risk up to the professional judgement of the individual environmental practitioner, which
has led to inconsistent interpretations of laboratory results undermining their credibility in the eyes
of clients, fellow practitioners, physicians and the courts. While the need to establish quantitative
HGV’s is widely recognized as evidenced by the numerous organizations over the past 30 years who
have attempted to establish valid and reliable risk levels (Supplemental Data S1),51 these values have
not been supported by a body of rigorous research that informs dose-response relationships, and
consequently none of these attempts have proved sustainable. To achieve the long elusive goal of
establishing dose-response based quantitative health guidance values for indoor airborne mold,
researchers will need to design their studies such that results can be translated into practice and
policy.
It is important to recognize that while air sampling results are an integral component of indoor
environmental assessments, a properly conducted indoor environmental investigation in response to
an occupant or building manager concern about water damage, mold conditions and/or a respiratory
health condition, or in response to a physician referral, should rely on a comprehensive evaluation of
visible water damage and mold, discernable mold odor, and excessive moisture conditions in
accordance with the criteria established by the WHO for dampness and mold conditions that are
associated with asthma and other adverse respiratory health complaints8. Such investigations, in
accordance with AIHA Guidelines, should be conducted by a competent professional and include
obtaining a history of water damage events that may suggest the presence of hidden mold growth
conditions in wall and ceiling cavities and beneath floors that would require a more invasive
inspection and an evaluation of the hygienic conditions in the air conditioning systems such that a
comprehensive plan for any necessary remediation can be developed9,10. It is also critical that the
source of the water damage that caused the mold growth be investigated and definitively determined
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such that the potential for recurrence of water damage and mold growth conditions can be
minimized52.
Another issue that this systematic review highlights is that of the 21 studies described on Table 3, 19
used culture-type air sampling methodology and only two used sporetrap sampling methodology.
However, a telephone survey of four major U.S. and Canadian laboratories that we conducted found
that environmental practitioners take > 90% of their samples using sporetrap methodology.
Therefore, for research to be translatable into both practice and policy, researchers should consider
using sporetrap sampling when designing their study methods. It is noteworthy that none of the 32
studies on Table 2 reported or considered the species of Penicillium, Aspergillus or other genera in
their analyses, and therefore the AIHA guidelines (which require the determination of species by
culture method) are not well aligned with the methods in general use by either the practitioner or
research communities. The authors of this paper recognize the value of culture-type sampling, which
enables the identification and quantitation of species, and also recognize there are limitations
affecting the validity and reliability of both sporetrap-type and culture-type air sampling results9,10.
These limitations include the temporal variability of air sampling results. Temporal variability is also
a factor with two of the WHO recognized D/M markers. Mold-related odors are affected by the
elapsed time since the last heavy rainfall, and condensation-related excessive moisture tends to be a
warm weather phenomenon, occurring when warm, humid air comes into contact with cold/chilled
water pipes and other cool surfaces. Just as with these other recognized D/M factors, while mold air
sampling results are subject to temporal variability, such variability produces primarily type II (false
negative) errors that drive the measured strengths of association toward the null. The findings of this
study, where 20 of the 21 studies cited in Table 3 found that exposure to elevated levels of airborne
mold by atopic persons posed a significant risk of adverse respiratory health outcomes, provide a
compelling argument that air sampling for mold, while not a stand-alone tool for assessing risk, is
nonetheless a useful and valid tool, especially considering that in 15 of these 21 studies, air samples
were taken only at a single point in time, as is generally the case with air samples taken by
environmental practitioners in the course of their investigations.
There are three major reasons for the shift by environmental practitioners away from the use of
culture-type air sampling and toward the use of sporetrap-type air sampling that has occurred
steadily over the past 20 years: 1) Turn-around time – culture-type sampling takes 10-14 days
compared to 1-2 days for sporetrap-type sampling; 2) Cost – culture-type sampling costs, especially
for full speciation of both Aspergillus and Penicillium, are substantially higher than for sporetraptype sampling, and; 3) Convenience and ease of use – culture-type sampling requires greater
preparation, higher skill levels, and greater care with samples53. Despite these cited advantages for
sporetrap-type sampling, it should be recognized that culture-type air sampling must be used by
environmental practitioners in cases where it is important to know not only the genera of mold in the
indoor air but also the species. These situations include investigations involving fungal infections
such as Aspergillosis, and cases where the mold air sampling results may be of interest to a
physician who is evaluating the associations between the genera and species of mold found in
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clinical (skin or serum) testing, using mold antigen extracts that are species-specific, and the
environmental findings.
Of the 18 studies cited on Table 3 that used culture-type sampling methodology and found
significant associations between exposure to elevated levels of airborne mold and adverse respiratory
health outcomes, the genus of mold associated with the outcome was Penicillium in ten studies,
Cladosporium in five studies (none in the U.S.), Alternaria in three studies, Aspergillus in two
studies, Basidiospores in two studies, Epicoccum in one study, and Stachybotrys in one study (Note:
there were multiple associations in some cases). The predominance of Penicillium as the genus most
frequently associated with adverse outcomes in U.S. studies, especially in contrast to Aspergillus, is
highly informative with respect to environmental consultants’ recognizing that their chains of
custody for culture-type air samples should generally request full speciation of not only Aspergillus
but also of Penicillium. A recent study by Sothern et al. (2018) found that over 90 percent of the
analysis requests received by a major U.S. environmental laboratory for culture-type air samples
requested full speciation for Aspergillus only, and that study also found that species of Penicillium
detected in the indoor air of complaint homes represented 19.1 percent of the total indoor fungal
flora contrasted to 13.0 percent for Aspergillus54.
While Penicillium is the genus most frequently associated with adverse respiratory health outcomes
in the U.S., as cited in Table 3, Dharmage et al. (Australia, 2001)25 found a significant risk of
bronchial hyperreactivity (BHR) with a doubling of exposure to both Penicillium and Cladosporium,
Matheson et al. (Australia, 2005)33 found an increased risk of asthma with doubling of exposure to
Cladosporium only, and Vicendese et al. (Australia, 2015)47 similarly found an increased risk of
hospital readmission for asthma with a doubling of exposure to Cladosporium only. Arikgolu et al.
(Turkey, 2016)48 also found an increased risk of asthma among children exposed to elevated levels
of indoor Cladosporium as did Polyzoi et al. (Canada, 2017)50. These finding suggest that the species
or subtypes of Cladosporium found in these countries may be more allergenic than in the U.S. or that
the populations may be more immunologically susceptible.
Susceptibility Type Selection Bias in Observational Studies with Allergic Disease Outcomes
Case-control studies can be subject to selection bias if the controls do not closely resemble the
population from which the cases are drawn, and selection of controls is considered to be one of the
most difficult aspects of case-control study design.55 In case-control and other types of observational
studies where the outcome variable is an allergic disease such as asthma, a specific type of selection
bias, which we are calling susceptibility bias, may have the potential to affect the validity of the
associations between environmental exposure to an antigen such as mold and an allergic disease
outcome. That is, unless the necessary data is collected and carefully considered, and the participant
selection process assures that all study participants have similar susceptibility to experiencing an
antigenic immunological response to the provoking environmental exposure factor, then the
associations that are found in the study are likely to be erroneous, and susceptibility bias would drive
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the strength of association toward the null. In this systematic review, we considered studies where
susceptibility bias was not adequately accounted for, and where measures of effect (OR’s, RR’s and
p values) were found to be below the level of significance, not to have met our secondary inclusion
criteria.
We reviewed the methods by which susceptibility bias was accounted for in each of the 32 studies
on Table 2, and we considered 19 of these studies to have sufficiently accounted for susceptibility
bias. Of these 19 studies, two used skin prick testing to assess IgE response, which is a measure of
atopy, 10 used family history, where studies have found that the risk of atopy and asthma increases
by a factor of two to three when one parent or sibling has asthma and by a factor of three or higher
when both parents have asthma56-58, and seven selected only participants who had the health
condition of interest.
Assessing the Impact of Using Log-Normalized Exposure Data in Measures of Effect Calculations
To test the effect of researchers’ use of log-normalized exposure data in their statistical analysis of
measures of effect, on Table 3 we separated the eight studies that did not use log-normalized data
from the 13 studies that did used log- normalized data. Given that indoor air sampling exposure data
appears to be uniformly right skewed in these studies, and in another study of 24,455 indoor air
samples taken from complaint homes as found by Sothern et al. (2018)54, we were concerned that log
normalizing the exposure data could have a negative impact on the validity of the calculated
measures of effect as suggested by Feng et al. (2014)59. However, the results shown in Table 3,
where the studies were divided into two groups (studies that did and did not log-normalize exposure
data), demonstrate that log normalizing exposure data did not appear to have a significant effect on
the acceptance or rejection of the null hypothesis in these studies.
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Strengths and Limitations of this Study
A strength of our study is the literature search strategy, which included a complete review of all 11
of the topic-relevant systematic and meta-analyses listed in Table 1. The authors of these 11 studies
had searched multiple databases and had also conducted critical appraisals of eligible studies,
including a review of publication bias. Of the 21 observational studies that met our primary and
secondary inclusion criteria, 17 studies (published from 1998 to 2014) had met the eligibility criteria
of one or more of these systematic reviews (Table 1). However, a limitation of our study is that the
remaining four articles (published from 2015 to 2017) that met our inclusion criteria were the
product of our PubMed search and were not subjected to a critical appraisal.
Another strength of our study is that to our knowledge, and based on our literature review, our
systematic review is the first to have isolated and examined only those studies that considered the
associations between exposure to elevated levels of mold in the indoor air and adverse respiratory
health outcomes. This enabled the authors of our study to assess the uniformity and strengths of
these associations and to produce findings and define research gaps that we hope will have
implications for researchers, practitioners, and policy makers.
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Supplemental Data
S1. History of published HGV’s and MRL’s for airborne mold adapted from Rao et al.51 (1996)
Organization
ACGIH/Guidelines for the Assessment of
Bioaerosols

Year
1989

ACGIH/Air Sampling Instruments for
Evaluation of Atmospheric Contaminants

1995

AIHA/Biohazards Ref. Manual

1986

AIHA/The Industrial Hygienist's Guide to
IAQ Investigations
AIHA/The Practioner's Approach to IAQ
Investigations

1993

CEC/Report#12: Biological Particles in
Indoor Environment

1993

CMHC/Determination of Fungal Propagules
in Indoor Air

1988

CMHC (Disclaimer)Testing of older houses
for microbiological pollutants

1991

Cutter Information Corp./IAQ Update:
Biocontaminants in Indoor Environments

1994

1989

Recommendations
•<100 CFU/m3 = OK
•Indoor/outdoor < 1 = OK if similar taxa
•Complaint area/Non-complaint > 10X = unusual
•<100 CFU/m3 = low: e.g. cleanrooms and hospitals
• 100-1000 CFU/m3 = intermediate: e.g. general indoor
and outdoor concentrations
•>1000 CFU/m3 = high: e.g. animal handling areas
•There is no safe level of an uncontained pathogenic
organism
•Rank order assessment
•Indoor/outdoor comparison recommended
•Rank order assessment
•>1000 CFU/m3 = indicates atypical situation
•High indoor/outdoor ratio = indoor amplifier present
For houses:
•>104 CFU/m3 = very high
•<104 CFU/m3 = high
•<103 CFU/m3 = intermediate
•<200 CFU/m3 = low (<500 CFU/m3 on DG18 medium)
•<50 CFU/m3 = very low
For non-industrial indoor:
•>2000 CFU/m3 = very high
•<2000 CFU/m3 = high
•<500 CFU/m3 = intermediate
•<100 CFU/m3 =low
•<25 CFU/m3 = very low
•0 CFU/m3 = no action unless indicated by inspection
•>50 CFU/m3 if one species = identify source to determine
further action
•< 150-200 CFU/m3 if several species = no action unless
indicated by inspection
•>200 CFU/m3 if several species = prudence requires
further inspection
•<400-500 CFU/m3 mainly Cladosporium and
Alternaria = no action unless indicated by inspection
•>500 CFU/m3 mainly Cladosporium and Alternaria =
determine reason
•>200 CFU/m3 variety of species other than Alternaria and
Cladosporium = investigate
•>500 CFU/m3 including Alternaria and Cladosporium =
investigate
•Indoor/outdoor comparison recommended when <200
CFU/m3
•Indoor/outdoor ratios range from < 0.1 to < 1 = OK
•Upper limits range from:
•300 CFU/m3 of common fungi (e.g. Cladosporium)
•150 CFU/m3 of mixed species other than pathogenic or
toxigenic species
•200 CFU/m3 total fungi
•100 CFU/m3 unless immunocompromised population
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•<750 CFU/m3 total airborne bacteria and
fungi = OK if species not infective or allergenic
•<300 CFU/m3 common fungi = OK
•<150 CFU/m3 mixed fungi other than pathogenic or
toxigenic = OK
•Toxigenic, pathogenic fungi not acceptable
in indoor air.
•>50 CFU/m3 if one species = investigate
•<150 CFU/m3 if mixture of species = OK
•<500 CFU/m3 if common tree/leaf fungi = OK in summer
•>104 CFU/m3 total fungi = threat to health
•>500 CFU/m3 of one species of a potentially pathogenic
nature = threat to health

Healthy Buildings International

1994

IAQ Association Inc./IAQ Standard #95-1
Recommended for Florida

1995

National Health and Welfare, Canada
(Disclaimer)/IAQ in Office Buildings: A
Technical Guide

1993

The Netherlands/Research Methods in
Biological Indoor Air Pollution

1989

New York City/Guidelines on Assessment
and Remediation of S. atra in Indoor
Environments
Nordic Council/Criteria Documents from
the Expert Group
Russian Federation (Standard)/MAC of
Harmful Substances

1995

•Indoor/outdoor > 1 = indicates contamination
•103-104 CFU/m3 = immediate evacuation

1991

USOSHA/Proposed IAQ Standard

1994

USOSHAATechnical Manual

1992

WHO/IAQ: Biological contaminants

1988

• 10-104 CFU/m3 = typical in "sick buildings"
and ambient air
•Levels from 103 cells/m3 to 104 cells/m3 depending on
specific species
•Some levels based upon metabolite or protein
concentrations
•Levels of bioaerosols in the indoors would reflect those
outdoors
•Rank order assessment
•>1000 CFU/m3 = indicates contamination
•>106 fungi/gram of dust = indicates contamination
•>105 bacterial or fungi/ml of stagnant water or slime =
indicates contamination
•Pathogenic and toxigenic fungi unacceptable in indoor air
•>50 CFU/m3 of one species = investigate
•<150 CFU/m3 = OK, if mixture of species
•<500 CFU/m3 = OK, if Cladosporium or other common
phylloplane

1993
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ABSTRACT
Background: Environmental consultants who perform indoor environmental inspections of homes
that have sustained water damage routinely conduct air sampling and use the results together with
other findings to guide health protective advice to occupants. However, there are no authoritative
recommended exposure limits to guide the interpretation of air sampling laboratory results, and
leading researchers have recognized the need for studies that would inform dose-response based
exposure levels that represent a respiratory health risk to atopic occupants of damp and moldy
homes.
Objective: To evaluate the quantitative levels at which exposure to elevated levels of water damagerelated genera of mold in the indoor air is associated with a significantly increased risk of wheeze
among atopic children.
Methods: In this nested case-control pilot study, indoor air samples for mold and outdoor controls
were collected by spore-trap method from the homes of 34 six and seven year old children selected
from within the 1,543-member Infant Wheeze Cohort in Havana, Cuba established by the Instituto
Nacional de Higiene, Epidemiología y Microbiología (INHEM) in 2010/2011. Cases and controls
were randomly selected from a pool of eligible participants with a family history of asthma.
Results: Analysis of the air sampling laboratory results found Penicillium/Aspergillus (Pen/Asp)
mold at levels > 200 structures/ m3 (str/m3) higher than outdoors in 13 of 34 homes (11 cases, 2
controls), indicating a significant risk of wheeze among children exposed to these levels: (OR 11.0
95% CI, 1.89-64.07). Analysis of the air sampling laboratory results found Cladosporium mold at
levels > 200 str/m3 higher than outdoors in 10 of 34 homes (6 cases, 4 controls), indicating there is
not a significant risk of wheeze among children exposed to these levels: (OR 1.5 95% CI, 0.34-6.70).
Levels of Pen/Asp in the outdoor air in New York and Cuba were found to be within the same range
in both geographies and climates.
Conclusion: Children with a family history of asthma exposed to elevated levels of Pen/Asp type
mold in the indoor air at a dose level of > 200 str/m3 higher than outdoor are at significant risk for
wheeze. The strength of association between exposure to elevated levels of airborne mold and
wheeze found in this pilot study supports our hypothesis that air sampling results can be a useful tool
in providing health protective advice to occupants and their physicians. The results of this study
suggest that defining elevated levels of mold as indoor levels of Pen/Asp > 200 str/m3 higher than
outdoor levels may be a useful starting point/benchmark for examination in larger similarly designed
studies that can test the reliability of this quantitative value.
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Introduction
According to the U.S. Centers for Disease Control and Prevention (CDC), over 24 million
Americans or 7.8% of the U.S. population suffer from current asthma (defined as having suffered an
asthma episode within the past 12 months)1, and according to the 2004 National Cuban Survey on
Asthma, the national prevalence rate of asthma in Cuba was found to be 13%2, or 67% higher than in
the U.S. Over 6 million or 8.4% of children in the U.S. suffer from current asthma, making asthma
the leading chronic disease among children in America1, and in Cuba the prevalence rate of asthma
among children was found to be 17.8%3. In New York City, the asthma prevalence rate for children
living in low-income public housing was found to be 21.8%, two to three times higher than in other
types of housing.4
Three major systematic reviews (IOM 20045, WHO 20096, Mendell et al. 20117) have concluded
that there is “sufficient evidence of an association” between exposure to dampness in indoor
residential and school environments and significantly increased risk of asthma, cough, wheeze,
upper respiratory symptoms and hypersensitivity pneumonitis. The WHO has defined the markers of
dampness as visible mold, visible water damage, visible or measurable excessive moisture and/or a
musty odor.6 However, the authors of the IOM and WHO reviews found that there was insufficient
evidence on which to base quantitative values for dampness and mold (D/M) levels that would
present a respiratory health risk to atopic occupants. The authoritative and widely cited 2011
systematic review (479 citations) conducted by Mark Mendell of the CA Department of
Health/Berkeley National Laboratory et al. goes even further, concluding that “current evidence does
not support measuring specific indoor microbiologic factors to guide health-protective actions.”7
However, Mendell recognizes the need for further research, and in 2015 published his
recommendations A Research Agenda on Assessing and Remediating Home Dampness and Mold to
Reduce Dampness-Related Health Effects (supported by the U.S. Department of Housing and Urban
Development) that pose a series of research questions that need to be answered by new and
rigorously designed studies that will contribute to the development of quantitative dose-response
based health guidance values for dampness and mold (D/M).8 In response to that challenge, the
authors of this paper designed a 200 home nested case-control study (to be conducted in Havana,
Cuba during 2018/2019) where participants will be randomly selected from within the remaining
1,106 children who were participants in the Infant Wheeze Cohort (HINASIC, Historia Natural de la
Sibilancia en La Habana, Cuba) established by INHEM in 2010/20119, and where the associations
between quantitatively assessed exposure to each of the four current WHO recognized markers for
D/M (visible mold, visible water damage, mold odor and excessive moisture) and asthma will be
assessed. In addition, the association between exposure to a fifth D/M marker, exposure to elevated
levels of airborne mold and asthma will be assessed, and in preparation for this 200 home study, the
authors designed and conducted a 34 home nested case-control pilot study, which is the subject of
this paper, where air samples for mold were collected from each home and from outside each home,
and laboratory results were analyzed to assess the association between exposure to elevated levels of
mold in the indoor air and symptoms of wheeze.
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Indoor air sampling for mold is routinely conducted by environmental practitioners as part of their
indoor environmental assessments in homes where occupants report respiratory health symptoms
and/or water damage and mold concerns (complaint homes), and the associated laboratory results are
used to guide recommendations for health protective actions. However, currently there are no
generally accepted quantitative guidelines defining elevated levels of mold in the indoor air issued
by government agencies, the American Industrial Hygiene Association (AIHA) or other professional
organizations, and therefore environmental consultants conducting indoor air quality evaluations use
their best judgement to interpret air sampling results, giving host to a wide range of interpretations.
It is hypothesized that the results of this pilot study will both add to the body of evidence that
validates and supports the use of and usefulness of spore-trap air sampling methodology and help to
establish a useful starting point/benchmark for defining elevated levels of mold in the indoor air that
can be assessed for reliability in larger, similarly-designed studies.
Methods
Selection of Cases and Controls
In this nested case-control pilot study, participants were selected from the 2010/2011 INHEM Infant
Wheeze Cohort9 in accordance with the following criteria:
1. The original 2010/2011 HINASIC Cohort was comprised of 1,956 infants aged 12-15 months
living in 17 randomly-selected polyclinic catchment areas within four of the 15 municipalities in
Havana, Cuba, and at the time participants were selected for this pilot study (2012/2013
questionnaire), the cohort was comprised of 1,543 three and four year old children. For this pilot
study, participants were selected from two of the four municipalities, reducing the eligible pool
to 799 children.
2. Questionnaires are administered annually directly by the family pediatrician to the parents of
each remaining participant in the cohort, and this pilot study included only those children whose
parents answered “yes” to one or more of the questions about “family history of asthma”
(2010/2011 questionnaire) and “yes” to the question about "visible mold/dampness" (2012/2013
questionnaire), leaving a pool of 95 eligible children. Parents of 69 of these children answered
"yes" to the question "any wheeze in the past 12 months" and parents of 26 of these children
answered "no" (2012/2013 questionnaire).
3. From this remaining pool of eligible participants, a total of 36 participants were randomly
selected for this pilot study, 18 cases (wheeze) and 18 controls (no wheeze).
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Air Sample Collection and Laboratory Analysis
Air samples for mold were collected from February through June 2016 onto Air-O-Cell spore trap
cassettes using Zefon Bio-Pumps calibrated to collect air at 15 Liters/minute (LPM) for five minutes
in accordance with the manufacturer’s instructions. A Professor of Biology and a Doctoral Candidate
at the University of Havana, who were trained in taking air samples in accordance with the
manufacturer’s instructions, collected two air samples from each home, one from the indoor air
(child's room) and one from the outdoor air directly outside the home. The House Code and Child
Code numbers were entered onto each Air-O-Cell cassette and onto the field data collection report
for each home. In two instances, there were problems with the codes entered onto the indoor and
outdoor cassettes, and for these two homes, the samples were not analyzed leaving 34 participants
(18 cases and 16 controls). Those collecting the samples were not informed as to the case or control
status of the home being sampled. The Air-O-Cell cassettes were retrieved from Cuba and analyzed
by EMLab P&K laboratories in New Jersey in accordance with the manufacturer’s instructions.
Sporetrap-type air samples are analyzed by direct microscopic examination, which allows for
identification and quantitation of viable and nonviable (without differentiation) fungal spores and
structural fragments to the genus/genera level only.10
Laboratory Results Interpretation
Laboratory results were interpreted by comparing indoor levels to outdoor levels in accordance with
AIHA guidelines to determine if the indoor air contains elevated levels of any fungi/mold related to
water damage conditions (“marker fungi”) contrasted to the outdoor air that would indicate the
presence of a mold problem in the home and/or a health risk to atopic occupants. 10,11 The primary
“marker fungi” are Penicillium and Aspergillus; however, because these two genera cannot be
morphologically distinguished by direct microscopic examination, laboratory results were reported
as the combined total spores and structural fragments (expressed collectively as structures per cubic
meter or str/m3) of Penicillium/Aspergillus (Pen/Asp). Previous research studies evaluating the
associations between exposure to elevated levels of indoor airborne fungi and adverse respiratory
health outcomes have found that Penicillium and Cladosporium are the genera most frequently
associated with adverse outcomes.12-17
Statistical Analysis
Based on a review of the laboratory results and previous research14,15,17, the exposed group was
defined as children who lived in homes where the levels of Pen/Asp and Cladosporium detected in
the indoor air was higher than the levels detected in the outdoor air by > 200 str/m3. Odds ratios and
95% confidence intervals were calculated to assess the strengths of association between exposure to
elevated levels of these fungi and wheeze using dichotomous logistic regression. Adjusted odds
ratios were calculated for the other major covariates not controlled for in the case-control selection
criteria: one or more smokers in house vs. no smokers in house and male sex of the child that were
identified in the study that established the HINASIC Cohort9.
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Results
Table 1 shows the indoor (child’s room) and outdoor concentration levels of Pen/Asp “marker fungi”
and Cladosporium detected in the indoor and outdoor air for each of the 34 (18 cases and 16
controls) homes in the study.
Table 1: Pilot Study – Summary of Sampling Results (concentration levels in str/m3)
House
Child code
Indoor
Outdoor Indoor Outdoor Elevated* Pen/Asp Elevated* Clad
Group
code
(Code)
Pen/Asp Pen/Asp
Clad
Clad
yes=1 no=0
yes=1 no=0
5
46108
Case
0
0
0
320
0
0
12
46117
Case
320
0
110
2500
1
0
18
47115
Case
6,200
160
4300
4600
1
0
25
47024
Case
0
0
210
0
0
1
28
47016
Case
1,000
0
800
3900
1
0
56
65058
Case
1,800
0
640
5000
1
0
57
65019
Case
1,100
0
5500
13000
1
0
58
65020
Case
1,100
0
5500
13000
1
0
59
65165
Case
1,800
0
4100
21000
1
0
60
65114
Case
2,500
210
2500
270
1
1
65
65004
Case
0
0
8200
2000
0
1
68
65053
Case
0
0
53
1700
0
0
73
65034
Case
0
0
2500
2600
0
0
74
65212
Case
370
0
60000
21000
1
1
77
65226
Case
590
0
22000
20000
1
1
79
65204
Case
0
0
7900
8600
0
0
98
66089
Case
850
53
4900
22000
1
0
100
66080
Case
0
5,100
3600
0
0
1
6
46116
Control
640
430
800
640
1
0
14
46103
Control
0
0
4700
5400
0
0
15
47078
Control
210
0
3500
4600
1
0
17
47038
Control
590
5,700
6200
1300
0
1
52
65090
Control
0
0
10000
16000
0
0
53
65225
Control
110
0
530
2200
0
0
63
65086
Control
0
110
690
3500
0
0
64
65084
Control
0
0
8400
7100
0
1
70
65103
Control
0
0
7600
26000
0
0
72
65195
Control
0
0
16000
8700
0
1
76
65076
Control
0
0
370
1000
0
0
78
65049
Control
0
0
2200
9700
0
0
80
65153
Control
0
0
1700
800
0
1
81
65217
Control
0
0
850
750
0
0
101
66082
Control
0
N/A
53
N/A
0
0
103
66091
Control
0
110
210
11000
0
0
*Elevated levels defined as indoor levels > 200 str/m3 higher than outdoor levels
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The air sampling results presented in Table 1 show that Pen/Asp airborne mold levels in the child’s
bedroom were > 200 str/m3 higher than outdoor levels in 13 of the 34 homes (11 cases, 2 controls),
indicating a significantly increased risk of wheeze among children exposed to Pen/Asp at these
levels (OR 11.0 95% CI, 1.90-63.83). After adjusting for one or more smokers vs. no smokers in
house and male sex, odds ratios continued to indicate significant risk for wheeze among children
exposed to Pen/Asp at these levels (OR 13.17 95% CI, 1.95-88.85). The air sampling results
presented in Table 1 also show that Cladosporium airborne mold levels in the child’s bedroom were
> 200 str/m3 higher than outdoor levels in 10 of the 34 homes (6 cases, 4 controls), indicating there is
not a significantly increased risk of wheeze among children exposed to Cladosporium at these levels
(OR 1.5 95% CI, 0.34-6.70).
Table 2: Mean Levels (str/m3) of Predominant Genera of Fungi in 34 homes in Cuba*
Fungi
Ascospores
Basidiospores
Cladosporium
Pen/Asp

Indoor
596
1777
5783
564

Outdoor
1078
1834
7278
360

*Includes all genera representing > 1% of total fungal organisms

The air sampling results presented in Table 2 show that there were only four genera representing
>1% of the total fungal organisms in both the indoor and outdoor air of the 34 homes, and that the
only genera where the mean indoor levels exceeded mean outdoor levels was Pen/Asp.
Table 3: Predominant Genera (str/m3) of Fungi in Outdoor Air - USA and Cuba*
Fungi
Ascospores
Basidiospores
Cladosporium
Pen/Asp

Typical Outdoor Data for New York in June20
Very low
Low
Medium
High
Very high
160
290
950
2800
5300
330
670
2400
7700
14000
110
210
640
1800
3100
27
43
130
390
710

Havana, Cuba
Mean value of 34 homes
1078
1834
7278
360

*Includes all genera representing > 1% of total outdoor fungal organisms
The outdoor air sampling results presented in Table 3 comparing mean outdoor levels in New York
in June18 to mean levels outside the 34 homes in the subtropical climate of Havana, Cuba (samples
taken February through June 2016) show that only four genera represented > 1% of total outdoor
fungal organisms in both geographies and climates. This data also shows that levels of Pen/Asp, the
water damage related fungi most frequently associated with adverse respiratory health outcomes,
were within the same range in both geographies and climates.
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Discussion
In this study, children exposed to elevated levels of Pen/Asp mold in the indoor air, (where indoor
levels exceeded outdoor levels by > 200 str/m3) were found to be at significantly elevated risk of
experiencing wheeze. While the size of our study (n=34) is small, there is a substantial body of
evidence where associations were found between exposure to elevated levels of indoor airborne
mold and adverse respiratory health outcomes, but where indoor air samples were collected and
analyzed by culture method. Müller et al. (2002)14 found an increased risk of respiratory tract
infection for children exposed to Penicillium at indoor levels > 100 CFU/m3 higher than outdoor
levels (OR 6.88 95% CI 1.21-38.9). Stark et al. (2003)19 found that infants exposed to airborne
levels of Penicillium in the home > 189 CFU/m3 (90th percentile) were at significantly increased risk
of wheeze and persistent cough (RR 1.73 95% CI 1.23-2.43). Rosenbaum et al. (2010)15 found that
infants exposed to airborne levels of Penicillium in the indoor air at levels ≥ 120 CFU/m3 were at
significantly increased risk of wheeze (OR 6.18 95% CI 1.34-28.46). Gent et al. (2012)13 found that
for asthmatic children sensitized to Penicillium, exposure to any Penicillium doubled the risk of
wheeze (OR 2.12 95% CI 1.12-4.04) or having a higher asthma severity score (OR 1.99 95% CI
1.06-3.72).
The culture method for air sampling and laboratory analysis is the method recognized and
recommended by the AIHA20,21, and this method has the advantage compared to the spore-trap
method of being able to identify and quantify viable fungal spores and structural fragments not only
to the genus level but to the species level, which is especially important because of the speciesspecific infectious potential of several fungi, most notably A. fumigatus, A. niger and A. flavus, and
because the antigen extracts used by clinicians for allergy testing are species-specific. However, as
discussed in a recent forum (Sloan Symposium 2018)22 among environmental practitioners,
academic researchers (including Mark Mendell), and leaders from government agencies, NGOs and
environmental laboratories, spore-trap sampling is by far the pre-eminent method of mold air
sampling used by environmental practitioners in their indoor environmental quality (IEQ)
assessments of D/M complaint homes because this method provides results within 1-2 days
(compared to 7-10 days by culture method), at lower cost and detects both viable and non-viable
spores and structures, which is important because non-viables are equally capable of provoking
allergic responses in sensitized persons. Therefore, there is a general consensus among these
professionals and leaders that there is an important need to establish quantitative dose-response
criteria for interpreting spore-trap method laboratory results that will assist environmental
practitioners and physicians in providing valid and reliable health protective advice to residents,
especially those with increased risk for adverse respiratory symptoms, regarding the need for
environmental intervention or possible temporary relocation. It is also important to recognize that
while air sampling is a useful and widely used tool in assessing D/M conditions in the indoor
environment, air sampling results should not be used as a stand-alone tool, especially considering the
issue of potential temporal variability, and should be used judiciously in conjunction with the
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currently recognized four WHO criteria (visible mold, visible water damage, excessive moisture or
mold odor) in the assessment of D/M conditions in the indoor environment.
A strength of our study is that the methodology for air sampling and laboratory results interpretation
is aligned with the methods prescribed by the AIHA10,11 with respect to taking indoor and outdoor
control samples in each home and comparing indoor to outdoor levels by genus/genera, such that
the results add to the body of research that can be translated into practice and policy. The limitations
of our study include the small sample size that has the potential to detract from the reliability of the
results, and the study’s retrospective design where participant status as a case or control was
assessed based on the 2012/2013 questionnaire results and samples were taken in 2016. This
limitation will be remedied pre-publication for both this Pilot Study and in the larger 200-home
nested case-control study.
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Abstract
RATIONALE: Epidemiological studies have demonstrated that exposure to fungi and molds
can play a role in a variety of diseases in susceptible individuals. Species-specific mold antigen
extracts are used to assess clinically suspected mold-related conditions, however these extracts
may not be aligned with the species of mold identified in the indoor and outdoor environment.
OBJECTIVES: To identify the predominant genera and species of molds in the air of homes
with water damage, mold growth, and/or occupants with respiratory complaints, and to assess the
concordance between these genera and species and the mold antigen extracts used in clinical
practice.
METHODS: Results of culture-type indoor air samples collected from 2002-2017 from homes
with reported water damage, mold growth, and/or occupants with respiratory symptoms were
examined. The final datasets included 24,455 indoor air samples taken from 7,547 complaint
homes from regions throughout the U.S. and Canada. Physicians were surveyed and the variety
of mold antigen extracts available from major clinical laboratories and antigen extract
manufacturers was assessed to identify those available and commonly utilized for serum and skin
testing. Concordance between the genera and species of mold in the indoor air of complaint
homes and the genus/species-specific antigen extracts used by clinicians to assess potentially
mold-related symptoms/disease was then evaluated.
MEASUREMENTS AND MAIN RESULTS: The predominant genera and species of molds
identified in complaint homes were poorly aligned with the species-specific mold antigen
extracts currently utilized by clinicians to assess patient mold allergies. For the Aspergillus genus
>50% and for the Penicillium genus >80% of the fungal organisms found in complaint homes are
species that are absent from the antigen extracts used by clinicians, potentially resulting in underdiagnosis of mold-related symptoms and disease.
CONCLUSIONS: Improving the alignment between the genus and species-specific mold
antigen extracts used by clinicians and the predominant genera and species of mold found in
complaint homes has the potential to improve patient outcomes by increasing recognition of the
need to assess and remediate water damage and mold conditions, interventions which have been
demonstrated to reduce risk to occupants with asthma and hypersensitivity pneumonitis.
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Introduction
Fungi and molds (a group of visible fungi that aggregate and grow as multicellular hyphal
filaments) are ubiquitous, vary between indoor and outdoor environments and by geographic
area and season, and in the vast majority of cases do not cause disease in humans (1-4).
However, exposure to certain environmental molds is recognized to play a role in a variety of
diseases including asthma, allergic rhinitis, sinusitis and hypersensitivity pneumonitis (HP),
leading to significant adverse health effects in susceptible individuals (3, 5, 6). Epidemiological
studies have linked specific indoor (Penicillium, Aspergillus and Candida) and outdoor
(Alternaria alternata and Cladosporium herbarum) fungal organisms to human disease (7, 8).
However, exposure to indoor dampness and molds is common (4), and the role of other
organisms commonly found in damp indoor spaces such as Stachybotrys chartarum and
Chaetomium, though associated with human disease, remains controversial (9). Fungi cause
human disease through a variety of mechanisms including inciting immune responses such as
allergy and inflammation, infection and reactions to fungal byproducts (6). Fungi are associated
with a variety of allergic lower respiratory tract disease states (10).
Evaluation of suspected mold-related disease includes a clinical assessment with a
particular focus on exposures including the presence of dampness, visible mold and mold odor,
building age, history of flooding or water damage, the relationship of symptoms to exposure,
time spent indoors and outdoors and seasonality of symptoms (7). Skin prick and intradermal
testing with fungal extracts are used to evaluate allergic sensitization in vivo; for serologic
testing, a panel of IgE antibodies to mold/environmental antigens are used as well. For
hypersensitivity pneumonitis, immunoprecipitation assays that include both IgG and IgE to
specific mold proteins are used (7). Fungal allergen components can also be assayed (11, 12).
These tests are an important component of the diagnostic workup and are frequently used by
clinicians to assist in the inclusion or exclusion of mold-related disease during the evaluation of
respiratory or other complaints. A significant limitation of these tests is cross-reactivity between
different antigens (7).
Diagnostic workup and management are complemented by procedures such as
environmental testing (13). The importance of environmental modification has been established
by the conclusions reached by leading environmental researchers who have found that the risk of
asthma recurrence is significantly reduced as a result of environmental intervention (i.e. mold
remediation) in the homes of asthmatic children (14,15) and similar risk reduction through
environmental intervention has been reported for patients with HP (16). However, the published
literature also strongly suggests that mold allergies are under-diagnosed (17,18), due in large part
to the well-documented reliability problems with the available mold antigen extracts (19,20,21)
used for allergy testing, resulting in the under-recognition of the need for environmental
intervention and where indicated, immunotherapy.
We hypothesized that in addition to the reliability problems with mold antigen extracts,
there is also a validity problem caused by poor concordance between the species of mold
identified on environmental testing and those included in commonly used skin and blood panels,
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potentially leading to under- or mis-diagnosis of allergic and lung diseases related to
environmental exposures. To test this hypothesis, a retrospective analysis of (n = 24,455) culturetype air samples collected between 2002 and 2017 was performed to assess the genera and
species of molds identified in residences of individuals reporting respiratory symptoms and/or
water damage. These results were compared to commercially available antigen extracts and
serum antibody assays for molds to assess concordance.
Methods
Air Sampling and Laboratory Methods for Included Data
Culture-type air samples were taken by industrial hygienists and other environmental
professionals in regions throughout the United States and Canada. The indication for air
sampling (e.g. performed in response to symptoms, water damage or visible mold growth), was
established by conducting a survey of environmental consultants (see Supplemental Data S1 for
questionnaire details). Air samples were collected utilizing the impactor method (Anderson or
BioCassette) whereby airborne mold spores and hyphal fragments are drawn onto a petri dish
containing a growth medium (most commonly malt extract agar) by a vacuum pump (19).
Samples were subsequently transported to EMLab P&K, an American Industrial Hygiene
Association (AIHA) accredited microbiological laboratory, and incubated at 25 ± 20C for 7-10
days followed by expert mycologist evaluation to identify and enumerate the genera/species of
fungi/molds present. Results were reported as colony forming units per cubic meter of air
(CFU/m3) for each genus and species identified.
Database and Dataset Generation
Two databases of all culture method air samples analyzed by EMLab P&K from January
1, 2002 to July 10, 2017, one for all samples analyzed to the species level for all genera
(n=9,362) and another for all samples analyzed to the species level for Aspergillus-only
(n=152,292) were compiled. Each line item on the two databases (total n=555,136) represents an
identification and quantitation of each genus and species recorded for each sample. As the study
focused on residential exposure, these databases were manually and electronically filtered to
generate 4 residential-only datasets comprised of full-speciation and Aspergillus-only indoor and
outdoor control samples (see Figure 1). The final full-speciation indoor residential dataset was
comprised of 1,119 air samples taken in 299 projects/locations, and the final full-speciation
outdoor control dataset was comprised of 1,194 air samples taken in 677 projects/locations. The
final Aspergillus-only indoor residential dataset was comprised of 23,336 air samples taken
in 7,248 projects/locations, and the final Aspergillus-only outdoor control dataset was comprised
of 28,299 air samples taken in 18,915 projects/locations.
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Antigen Extracts Available and Utilized Clinically
To determine the genus and species-specific mold antigen extracts and preparations most
commonly used for skin testing in clinical practice, questionnaires were administered to
allergists/immunologists in the New York City area (see Supplemental Data S2 for questionnaire
details). Additionally, the websites of U.S. Food and Drug Administration (FDA) approved mold
antigen extract manufacturers (22, accessed 3 March 2017) cited by respondents (StallergenesGreer, HollisterStier and ALK-Abello Inc) were reviewed to determine available mold genus and
species-specific mold antigen extracts (Supplemental Data S3). Similarly, to identify the genus
and species-specific mold antigens most commonly used for serum testing, physicians were
queried regarding the clinical laboratories they utilize, the mold antigen panels available, and the
tests most frequently performed. The websites of 3 prominent clinical laboratories (Quest
Diagnostics, LabCorps and ARUP Laboratories) were reviewed to determine the genus and
species-specific mold antibodies included in their respiratory and HP serum testing panels.
Statistical Analysis
The average CFU/m3, percent of total fungal organisms and the frequency (%) of
detection were calculated for each genus/species in each dataset (full-speciation indoor
residential and outdoor; Aspergillus-only indoor residential and outdoor). A procedure to identify
and evaluate outliers and remove erroneous data was carried out as described in Supplemental
Data S4. To determine the percent of total fungal organisms in the indoor and outdoor air by
geographic region for each of the most predominant species of Aspergillus (from the Aspergillusonly datasets) and Penicillium (from the full-speciation datasets), the datasets were further
analyzed by the major regions of the U.S. (Eastern U.S. states and Western U.S. states) from
which the samples were taken.
Results
Table I shows the results of our survey of environmental consultants (see Supplemental
Data S1 - Environmental Consultant Questionnaire), who collectively represent 13.8% of the
projects where the samples in the final residential datasets were collected. The consultants
reported that 96% of indoor samples from residential buildings were taken as a result of concerns
about occupant health and/or visible/hidden water damage or mold growth concerns (collectively
classified as complaint homes), consistent with a previous publication (2), with the most
common indication being health concerns/symptoms 58%.
Table II shows the average CFU/m3, the percent of the total fungal organisms/flora and
the frequency (%) of occurrence/detection for each genus/species in the indoor air of complaint
homes and in the outdoor air that represent ≥1% of either the indoor or outdoor fungal flora (see
Supplemental Data S5 showing the same data for each genus/species that represent ≥0.5% of
either the indoor air of complaint homes or in the outdoor fungal flora). The data shows that for
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the Aspergillus genus, A. sydowii and A. versicolor were found at significantly higher
concentrations in the indoor air of complaint homes than in the outdoor air. Similarly for the
Penicillium genus, P. aurantiogriseum, P. brevicompactum, P. citrinum, P. crustosum, P.
glabrum and P. variabile were found at significantly higher concentrations in the indoor air of
complaint homes versus the outdoor air, suggesting that these species of Aspergillus and
Penicillium may be classifiable as indoor “water-damage-related” fungi. It should be noted that
Stachybotrys chartarum, a mold of substantial public health interest was not detected at
significant levels in either the full speciation or the Aspergillus-only dataset. This absence of
detection likely relates to the fact that the predominant growth medium used for the samples in
these datasets was malt extract agar (MEA), which does not readily promote the growth of
Stachybotrys species.
Tables III and IV show the breakdown of the percent of total fungal organisms/flora data
presented in Table II for the predominant Aspergillus and Penicillium species by the major
region in the U.S. (Eastern states and Western states) from which the indoor samples and outdoor
control samples were taken. For the Aspergillus genus, A. versicolor, A. niger, A. fumigatus and
A. sydowii each represented >1% of the total indoor fungal organisms/flora in both regions and
for the Penicillium genus, P. citrinum, P. brevicompactum, P. chrysogenum and P. glabrum each
represented >1% of the total indoor fungal organisms/flora in both regions.
Supplemental Data S6 and S7 assess the reliability of the data in the smaller fullspeciation datasets (1,119 indoor samples and 1,194 outdoor samples) by comparing the percent
of the total fungal organisms/flora represented by each of the top eight species of Aspergillus in
that dataset to the top eight species in the much larger Aspergillus-only dataset (23,336 indoor
samples and 28,229 outdoor samples). The table in Supplemental Data S6 (indoor samples)
shows that: 1) the eight most predominant species of Aspergillus are the same in both datasets; 2)
the rank order is the same for the top three species in both datasets, and; 3) the rank order is
similar for the next five most predominant species in both datasets. The table in Supplemental
Data S7 (outdoor samples) shows that: 1) the eight most predominant species of Aspergillus are
the same in both datasets, and; 2) the rank order for each of the eight species is the same in both
datasets. These similarities infer a high degree of reliability for the Penicillium species data in
the smaller full-speciation database.
Table V analyzes the concordance between each genus and species of mold representing
≥1% of indoor fungal flora in complaint homes and the correlative genus and species-specific
antibody tests offered by Quest Diagnostics, LabCorp and ARUP for serum testing and the
extracts offered by prominent U.S. FDA approved antigen extracts manufacturers Stallergenes
Greer, HollisterStier, and ALK Abello that are used by the physicians interviewed for skin
testing. This analysis shows that for the Aspergillus genus, A. versicolor, the single most
predominant species of Aspergillus and A. sydowii, as well as seven of the eight most
predominant species of Penicillium found in complaint homes are missing from the commercial
serologic panels and the antigen extracts used for skin testing.
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Discussion
Exposure to mold can lead to a variety of adverse health effects in susceptible
individuals. Evaluation generally includes a clinical assessment, skin/serological testing and
environmental assessment; however, this retrospective evaluation of molds present in the indoor
air of water damaged residential buildings across the U.S. and Canada identifies significant
discordance between environmental molds and the mold antigen extracts available for clinical
assessment in the evaluation of suspected mold-related disease. This discordance has the
potential to reduce accurate clinical diagnosis and thereby reduce the opportunity to improve
health outcomes via avoidance of ongoing exposure through remediation of buildings (14,15,16)
and sometimes immunotherapy for mold allergy (23).
The FDA’s Center for Biologics Evaluation of Research (CBER) is responsible for
licensing manufacturers of antigen extracts and currently licenses only six manufacturers to
produce mold antigen extracts, which are used for diagnostic purposes both by
allergists/immunologists conducting skin testing to assess IgE antibody responses/levels and by
laboratories conducting in vitro serum testing to assess IgE and non-specific antibody
responses/levels to mold genus and species-specific antigen provocation. In addition, the mold
genus and species-specific antigens are used for therapeutic purposes by allergists/immunologists
who administer immunotherapy, a gradually increasing low-dose subcutaneous injection or oral
administration of an antigen extract intended to induce immunologic tolerance to an allergen
over time (24, 25). Previously published analyses cite variations of as much as a full order of
magnitude or more in the concentration (mg/mL) of mold genus and species-specific mold
protein antigen provided by the major mold antigen producers (19). These variations in antigen
strength and uniformity, which can occur even using identical allergen sources, can be attributed
to many factors including variability of strains within species, variation in culturing methods,
and variations in levels of enzyme degradation that may occur during extraction (17, 26). The
Esch article concludes that improving the accuracy of fungal allergy diagnosis will require a
coordinated effort by manufacturers, regulatory authorities, clinicians and researchers (19). The
reliability problems with mold antigens have long been recognized (27), and it is clear in the
very current published literature that reliability problems remain unresolved (17, 20, 26). The use
of purified molecularly cloned recombinant antigens that also provide specificity to each of the
multiple enzymes and other proteins present in many allergenic species is a promising
technology for providing reliable mold antigen extracts; however, while currently available for
research purposes, recombinants are not yet available for commercial use (17, 26).
Cross-reactivity occurs when a patient’s species-specific IgE or IgG antibodies react with
a different species-specific mold antigen extract in skin prick or serum testing (17, 28, 29).
Twaroch et al. (2015) (17) and Crameri et al. (2009) (30) have analyzed recombinant speciesspecific mold allergens and cross-reactivity and have identified prospective cross-reactivity
between different species of mold from within the same genus and from other genera, which may
mitigate several of the misalignments between the frequently detected environmental fungi and
the available antigen extracts shown in Table V. For example, C. cladosporioides may
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potentially cross-react with A. fumigatus and P. chrysogenum, and P. citrinum may potentially
cross-react with A. fumigatus, C. herbarum, and P. chrysogenum (17). However, our review of
the literature did not find that other species have been identified that cross-react with A.
versicolor, P. aurantiogriseum, P. brevicompactum, P. crustosum, P. glabrum, P. purpurogenum
or P. variabile (17, 30).
The reliability problems with antigen extracts are well-recognized (17) and are
contributing to the under-diagnosis of mold allergies (19). Our study focused on the extent to
which validity issues with the antigen extracts currently used by clinicians may also be
contributing to the under-diagnosis of mold allergies, and to do this we examined the
concordance between the genera and species of airborne mold that occupants of complaint
homes are exposed to in the indoor air and the genus and species-specific mold antigen extracts
used by physicians and clinical laboratories to assess patient mold allergies. As shown in Table
V, two species of the Aspergillus genus, A. versicolor which accounts for 5.78% of total fungal
organisms and A. sydowii which accounts for 1.35% of total fungal organisms, together comprise
>50% of the Aspergillus fungal organisms in complaint homes yet are not among the mold
antigen extracts currently used by physicians and clinical laboratories. This discordance could be
substantially remedied if physicians and clinical laboratories were to use the commercially
available A. versicolor antigen extract in their testing (see Supplemental Data S3); however, for
A. sydowii, it does not appear that a commercial antigen extract is currently available and would
therefore need to be developed. Table V also shows that there are seven species of the
Penicillium genus (P. aurantiogriseum, P. brevicompactum, P. citrinum, P. crustosum, P.
glabrum, P. purpurogenum and P. variabile) that collectively comprise >80% of the Penicillium
fungal organisms found in complaint homes yet are not among the mold antigen extracts used by
physicians and clinical laboratories. This discordance could be reduced slightly if physicians and
clinical laboratories were to use the commercially available P. brevicompactum antigen extract
in their testing (see Supplemental Data S3); however, for the other six Penicillium species, it
does not appear that commercial antigen extracts are currently available and would therefore
need to be developed.
Using and developing Penicillium antigen extracts that more closely represent the species
occupants of complaint homes are being exposed to takes on additional importance when
considering there is a substantial body of evidence where researchers have found that occupant
exposure to elevated levels of Penicillium in indoor air, in studies where air samples were
collected and analyzed using the culture-type method, is more closely associated with an
increased risk of asthma and other respiratory conditions than exposure to Aspergillus. For
example, Gent et al. (2002) (31) found that for infants, exposure to the highest levels of
Penicillium (≥ 1,000 CFU/m3) was associated with an increased risk of wheeze (RR 2.15 95% CI
1.34 - 3.46) and persistent cough (RR 2.06 95% CI 1.31-3.24). Stark et al. (2003) (32) found that
infants exposed to airborne levels of Penicillium in the home > 189 CFU/m3 (90th percentile)
were at significantly increased risk of wheeze and persistent cough (RR 1.73 95% CI 1.23-2.43).
Rosenbaum et al. (2010) (33) found that infants exposed to airborne levels of Penicillium in the
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indoor air at levels ≥120 CFU/m3 were at significantly increased risk of wheeze (OR 6.18 95%
CI 1.34-28.46).
Exposure to Penicillium has also been cited in several case studies where researchers
found that hypersensitivity pneumonitis (HP) was caused or induced by exposure to Penicillium
species in both residential and industrial environments (34-37). Lee et al. (2005) (34) reported a
case where a 30-year-old female housewife was diagnosed with HP (according to history, chest
radiograph, spirometry, high resolution chest CT, and transbronchial lung biopsy) caused by
exposure to airborne Penicillium species in her home. Park et al. (1994) (35) reported a case
where a 31-year-old atopic housewife was diagnosed with HP (bronchoalveolar lavage showed
an increase lymphocyte count with reversed CD4+/CD8+ ratio and transbronchial lung biopsy
showed markedly increased lymphocytic infiltration in alveolar septa). Penicillium expansum
was detected in air samples taken in the home, and double immunodiffusion test with the
patient’s serum showed two precipitin bands to P. expansum antigens. The patient’s symptoms
and abnormal clinical findings resolved after two months avoidance of her home environment.
Yoshikawa et al. (2007) (36) conducted a case series investigating new cases of HP among
workers cultivating Enoki mushrooms. Four out of 48 workers in the study were diagnosed (by
chest computed tomography, bronchoalveolar lavage, and transbronchial lung biopsy) with
having HP caused by exposure to P. citrinum.
The above cited studies and others examining the associations between exposure to
elevated levels of airborne mold, where samples were collected and analyzed using the culture
method, have identified Penicillium as the genus most frequently associated with adverse
respiratory health outcomes. However, as our study illustrates, the requests for analysis in the
preponderance of culture-type air samples taken by consultants and other investigators and
submitted to environmental laboratories for analysis request that these samples be analyzed to
the species level only for the Aspergillus genus. The results of our study suggest that the role of
Penicillium in complaint homes is currently underappreciated by environmental consultants,
environmental laboratories, and the clinical community.
The methodology used for mold collection warrants some additional discussion and
clarification. Environmental consultants have increasingly come to rely much more heavily on
sporetrap-type air sampling (where laboratory analysis is to the genus level only,
Penicillium/Aspergillus is reported as a single value, and results include both viable and nonviable fungal structures) than culture-type air sampling (where laboratory analysis is to the genus
and species level but results include viable fungal structures only) in their routine indoor
environmental investigations, as confirmed by our co-authors from EMLab P&K who report that
in 2017 the laboratory received 18 times the volume of sporetrap-type air samples compared to
culture-type air samples. This trend is understandable because the laboratory turnaround time for
sporetrap samples is generally same day or next day as opposed to seven to ten days for culturetype samples and laboratory fees are significantly lower for sporetrap-type sampling. However,
in cases involving asthma, HP and other allergic conditions where it is important for the client or
his/her physician to know the species of airborne mold to which the client is being exposed,
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thereby indicating the need for culture-type air sampling, full speciation of Penicillium as well as
Aspergillus should routinely be requested by the environmental consultant.
The database we compiled of 53,948 culture-type air samples for mold (24,455 indoor
and 29,493 outdoor) from 27,139 residential sites across the U.S. taken between 2002 and 2017
builds on the work of Shelton et al. (2) who compiled the results from 12,026 culture-type air
samples for mold (9,619 indoor and 2,407 outdoor) from 1,717 buildings located across the U.S.
collected during indoor environmental investigations between 1996 and 1998. The Shelton study
shares some similarities with our study in that the majority of the samples were taken from
complaint buildings and most samples were analyzed to the species level for the Aspergillus
genus; however, their study design was different from ours in that only 4% of the buildings from
which the samples were taken were residential buildings, and samples were not analyzed to the
species level for Penicillium. Despite these dissimilarities, the results of Shelton’s study with
respect to the Aspergillus genus were remarkably similar to the results of our study in that A.
versicolor was the species found to comprise the highest percent of total fungal organisms in the
indoor air, A. versicolor and A. sydowii were found at the highest mean concentration levels in
the indoor air, and the ratios of indoor to outdoor levels were also highest for A. versicolor and
A. sydowii, further suggesting that these species are classifiable as “water-damage-related” fungi.
There are a number of well-defined problems that have been cited by authoritative
professional organizations and researchers with respect to the validity, reliability and
interpretability of mold air sampling results (4, 38-41). Among the problems most commonly
cited is the issue of temporal variability of airborne mold levels, which is an issue the authors of
this paper acknowledge; however, given the large number of samples included in our study, it is
reasonable to expect that the effect of temporal variability on the mean concentration levels,
percent of total fungal organisms, and percent occurrence reported for each genus and species in
our study would be minimal. Another commonly cited problem is the potential for interlaboratory variability in the results reported by different laboratories for the same sample;
however, again considering the large number of samples included in our study and the study
conducted by Shelton, the consistency of the findings between these two major laboratories
suggest that the impact of inter-laboratory variability on the mean concentration levels, percent
of total fungal organisms, and percent occurrence reported for each genus and species in our
study is also likely to be minimal.
Air sampling for mold is conducted by environmental consultants as a normal component
of indoor environmental inspections that are conducted in complaint homes, which is
understandable considering that inhalation is the primary route of exposure to mold that triggers
allergic responses in atopic persons. However, the variability in interpretation of air sample
laboratory results is a significant issue, and the authors of this paper support the 2015 research
agenda (38) developed by Mark Mendell of the University of California, Berkeley and the
California Department of Health that calls for rigorously designed prospective studies that can
help to establish quantitative thresholds or health guidance values for mold that can be used by
health professionals in providing valid and reliable health guidance advice to clients and patients.
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Dust sampling for mold, where laboratory analysis is conducted using the DNA-based
method Quantitative Polymerase Chain Reaction (QPCR) method, which includes the EPA
patented Environmental Relative Moldiness Index (ERMI) method, is an evolving sampling
methodology that can be both useful and complementary to air sampling. However, currently this
methodology is used infrequently by indoor environmental consultants relative to other sampling
methods, and like air sampling there are intrinsic issues related to the interpretability of dust
sample results for mold, notably with respect to the length of time elapsed between the time the
surface was last cleaned and the time of sampling. There are also substantial misalignments
between the limited number of mold species included in the QPCR panels offered by
environmental laboratories and the predominant species of mold found in the indoor air of
complaint homes.
It is important to recognize that while air sampling results are a useful tool, a properly
conducted indoor environmental investigation in response to an occupant or building manager
complaint of water damage, mold conditions and/or a respiratory health condition should rely on
a comprehensive evaluation of visible water damage and mold, discernable mold odor, and
excessive moisture conditions in accordance with the criteria established by the WHO for
dampness and mold conditions that are associated with asthma and other adverse respiratory
health complaints (42). Such investigations, in accordance with AIHA Guidelines, should be
conducted by a competent professional and include obtaining a history of water damage events
that may suggest the presence of hidden mold growth conditions in wall cavities and beneath
floors that would require a more invasive inspection and an evaluation of the hygienic conditions
in the air conditioning systems such that a comprehensive plan for any necessary remediation can
be developed (40).
A strength of this study is the large sample size and geographic diversity of culture-type
air samples taken from homes across the U.S. and Canada. To our knowledge, this is the largest
residential mold sample testing cohort published to date, which adds to the generalizability of the
results.
However, this study has several limitations. The method of culture assessment might
create bias toward organisms that grow on common culture media versus PCR-based methods
that could potentially quantify a greater diversity of organisms. Mold exposure is common,
approximately 10% of the population has evidence of sensitization (IgE antibodies) to common
inhaled fungi (18), but not all exposed individuals will develop clinically important disease. The
findings of environmental fungi in the home environment may or may not establish a causal
relationship with a patient’s clinical symptoms, signs and radiographic abnormalities.
Despite these limitations, our data suggest that the sensitivity for clinical detection of
mold exposure has the potential to be significantly improved by the addition of mold species
frequently identified in damp and moldy home environments that are not currently included in
commercially available mold extracts/allergen panels and serologic tests for mold exposure.
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Figure 1. Database/Dataset Process Flowchart Diagram
Full-Speciation Database/Dataset
Database compiled for all culture method air
samples analyzed by species for all genera (N =
9,362) from January 1, 2002 to July 10, 2017

Sample location/description column manually screened
to identify and segregate samples taken from residences
using keywords "bedroom, living room, den, family
room, TV room, child's room, or baby room"

Sample location/description column manually screened to
identify and segregate samples taken outdoors using
keywords "outside, outdoors, front porch, back porch,
courtyard, driveway, balcony, exterior, patio and outside air"

Aspergillus-only Database/Dataset
Database compiled for all culture method air
samples analyzed by species for Aspergillus only (N
= 152,292) from January 1, 2002 to July 10, 2017

Sample location/description column electronically
filtered using same residential and outdoor
keywords as full-speciation dataset to create
interim indoor residential and outdoor datasets

Each line item in interim datasets manually
reviewed for electronic filtering error potential
and errors excluded

Datasets electronically filtered to include only impactor method
samples (Andersen-type or BioCassette)

Datasets electronically filtered to exclude samples with measurement
of 0 liters (i.e. blanks)

Manually identified samples > 3 SD for potential errors and errors excluded

Final full-speciation
indoor residential dataset
(N=1,119 air samples)
taken in 299
projects/locations

Final full-speciation
outdoor control dataset
(N=1,194 air samples)
taken in 677
projects/locations

Final Aspergillus-only
indoor residential dataset
(N=23,336 air samples)
taken in 7,248
projects/locations

Final Aspergillus-only
outdoor control dataset
(N=28,299 air samples)
taken in 18,915
projects/locations
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Table I: Survey of Environmental Consultants: Indication for Air Sampling1

Indication
Health concerns2
Visible fungi
Water damage/dampness
Moldy or musty odor
Proactive evaluation3

n (%)
58
10
16
12
4

1

Includes n=1,041 of 7,547 residential projects (13.8%)
Health concerns - includes asthma, allergic rhinitis, wheeze, cough, dyspnea, hypersensitivity
pneumonitis, headache, eye and skin problems, and other health issues.
3
Proactive evaluation - such as annual preventative samplings or pre-purchase inspections where samples
were taken in advance of any observed problem.
2
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Table II: Comparison of Indoor and Outdoor Data for Fungal Species Detected1
Average
CFU/m3
22.3
22.2
61.4
196.7
185.4

Indoor Residential
% of Total
Percent
Organisms2 Occurrence3
3.5
18.3
1.8
7.6
4.0
17.1
1.4
5.7
5.8
24.5
13.0
1.6
8
3.0
15.5

Average
CFU/m3
21.4
23.5
33.5
32.9
37.5

Outdoor Residential
% of Total
Percent
Organisms2 Occurrence3
6.1
30.9
2.2
9.8
5.5
24.5
0.2
1.1
1.3
5.9
9.3
1.6
8.3
5.8
29.3

Fungus
Alternaria alternate
Aspergillus fumigatus
Aspergillus niger
Aspergillus sydowii
Aspergillus versicolor
Subtotal Aspergillus genus
Aureobasidium pullulans
30.5
30.1
Basidiomycetes
52.6
91.5
Cladosporium
206.7
15.9
81.4
384.2
16.7
84.4
cladosporioides
Cladosporium herbarum
312.6
1.0
5.1
314.6
1.8
9.1
Cladosporium
148.8
1.1
5.6
158.4
0.8
3.9
sphaerospermum
Subtotal Cladosporium
18.0
19.2
genus
Curvularia lunata
27.7
1.4
6.9
27.4
0.8
4.0
Epicoccum nigrum
24.0
2.3
11.7
25.9
4.7
24.0
Non-sporulating fungi
22.2
6.7
34.4
18.8
7.6
38.7
Penicillium
196.3
2.7
13.8
61.7
1.3
6.7
aurantiogriseum
Penicillium brevicompactum
197.7
3.2
16.1
79.8
2.7
13.9
Penicillium chrysogenum
73.7
2.3
11.8
55.2
1.7
8.46
Penicillium citrinum
89.9
3.5
17.8
34.5
2.7
13.9
Penicillium crustosum
171.4
2.0
10.2
36.3
1.2
5.9
Penicillium glabrum
55.4
1.7
8.8
26.1
1.4
6.9
Penicillium purpurogenum
42.1
2.1
10.5
52.3
1.1
5.6
Penicillium variabile
136.1
1.7
8.9
29.7
0.6
2.9
Subtotal Penicillium genus
19.1
12.7
Pithomyces chartarum
22.5
1.0
5.3
21.5
0.9
4.6
Rhizopus stolonifera
14.0
1.1
5.5
11.8
0.8
4.3
Yeasts, other
36.4
3.3
17.1
39.0
3.3
16.8
Total samples Aspergillus
23,336
28,299
only dataset
Total projects Aspergillus
7,248
18,915
only dataset
Total samples full speciation
1,119
1,194
dataset
Total projects full speciation
299
677
dataset
1
For species representing ≥1% of total fungal organisms detected. For Aspergillus genus/species – data from
Aspergillus only dataset; for all other genera/species – data from full speciation dataset
2
Percent species represents of total fungal flora
3
Percent of samples in which the species was detected

78

Table III: Predominant Species of Aspergillus by Major U.S. Region from Aspergillus-only Dataset
From Aspergillus-only Dataset
Fungi

% Organisms
Indoor

% Organisms
Outdoor

% Organisms
Indoor

Residential (23,336 samples)
Aspergillus versicolor
Aspergillus niger
Aspergillus fumigatus
Aspergillus sydowii
Aspergillus ochraceus
Aspergillus ustus
Aspergillus glaucus
Aspergillus flavus

5.78%
4.03%
1.79%
1.35%
0.97%
0.73%
0.52%
0.43%

1.33%
5.51%
2.20%
0.24%
0.72%
0.19%
0.24%
0.85%

% Organisms
Outdoor

Eastern U.S. (5,012 samples)
7.52%
3.37%
1.05%
1.84%
1.49%
1.26%
0.71%
0.47%

1.32%
3.29%
2.02%
0.33%
0.40%
0.13%
0.25%
0.34%

% Organisms
Indoor

% Organisms
Outdoor

Western U.S. (11,375 samples)
5.14%
4.85%
2.69%
1.29%
0.69%
0.56%
0.57%
0.35%

1.37%
7.56%
2.89%
0.24%
1.00%
0.23%
0.20%
1.14%

Table IV: Predominant Species of Penicillium by Major U.S. Region from Full-Speciation Dataset
From Full-Speciation Dataset
Fungi

% Organisms
Indoor

% Organisms
Outdoor

Residential (1,119 samples)
Penicillium citrinum
Penicillium brevicompactum
Penicillium aurantiogriseum
Penicillium chrysogenum
Penicillium purpurogenum
Penicillium crustosum
Penicillium glabrum

3.48%
3.15%
2.70%
2.31%
2.05%
2.00%
1.72%

2.74%
2.74%
1.32%
1.67%
1.11%
1.16%
1.36%

% Organisms
Indoor

% Organisms
Outdoor

Eastern U.S. (374 samples)
5.03%
2.37%
0.60%
3.93%
0.81%
0.81%
2.42%

3.13%
2.45%
0.23%
1.66%
0.83%
0.53%
1.58%

% Organisms
Indoor

% Organisms
Outdoor

Western U.S. (404 samples)
3.22%
4.01%
5.84%
1.40%
1.76%
2.61%
2.19%

2.99%
3.96%
3.59%
1.94%
1.50%
1.57%
2.02%
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Table V: Concordance Between Indoor Molds and Antigens Available for Clinical Testing1
Fungi

Average
CFU/m3

Percent
Organisms
≥ 1% of
Total

Quest
Diagnostics
& LabCorp
Comb.
HP
Labs
and
Panels

Alternaria alternata

22.3

3.54

Aspergillus fumigatus

22.2

1.79

•

Aspergillus niger

61.4

4.03

•

Aspergillus sydowii

196.7

1.35

Aspergillus versicolor

185.4

5.78

Aureobasidium pullulans

30.5

1.56

Basidiomycetes
Cladosporium
cladosporioides

52.6

3.03

206.7

15.94

Cladosporium herbarum
Cladosporium
sphaerospermum

312.6

1.00

148.8

1.10

Curvularia lunata

27.7

1.35

Epicoccum nigrum

24.0

2.29

Non-sporulating fungi
Penicillium
aurantiogriseum
Penicillium
brevicompactum
Penicillium chrysogenum
(notatum)

22.2

6.74

196.3

2.70

197.7

3.15

73.7

2.31

Penicillium citrinum

89.9

3.48

Penicillium crustosum

171.4

2.00

Penicillium glabrum
Penicillium
purpurogenum

55.4

1.72

42.1

2.05

ARUP Lab.

Stallergenes
Greer
Lab

Hollister
Stier
Allergy

ALK
Abello
Inc.

Allergists
1-4

Comb.
Resp.
Region
Panels

Comb.
HP
Labs
and
Panels

Comb.
Resp.
Region
Panels

•

•

•

•

•

•

•

•

•

•

•

•

•

•

•

•

•

Skin Testing

•

•
•

•

•

•
•

•

•

•

•

•

•

•
•
•

•

•
•

•

•

•

•

•

•

•

•

•
•

•

Penicillium variabile
136.1
1.73
Pithomyces chartarum
22.50
1.03
Rhizopus stolonifer
14.0
1.07
Yeast, other
36.40
3.34
Total Samples Asp-only
dataset
23,336
Total Projects Asp-only
dataset
7,248
Total Samples Full-spec
dataset
1,119
Total Projects Full-spec
dataset
299
1
For genera/species representing >1% of total fungal organisms detected.

•

•

•
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Supplemental Data
S1 - Environmental Consultant Questionnaire
Hello,
EMLab P&K is participating in a study of the rates at which different fungi have been found in
culturable air samples taken from residences (not including hospitals and healthcare facilities,
schools, commercial offices, or manufacturing facilities) submitted to us by our clients over the
years.
As part of this study we would appreciate your feedback in helping determine what concerns
most frequently prompt the samplings that you perform. (Please note and keep in mind that we
are only looking for "best estimate” percentages based on your experience of the
reasons/concerns that prompted your taking the culturable air samples from residences that you
submitted to our labs in the past.)
If you can spare a few minutes, please indicate the percentage of your fungal culture-type air
samples that you estimate are due to each concern listed in the table below:
Concern:
Health*
Visible fungi
Water damage/excessive moisture
Moldy or musty-type odor
Proactive**
Total

Percentage of Culturable Fungal Air
Samples due to Concern:

100%

(For sampling events that were prompted by multiple concerns, place them in the higher category on the list; so
Health and Visible Fungi concerns would be placed under Health,
Visible Fungi and Water Damage concerns would be placed under Visible Fungi, pre-purchase samplings
originating from a Health or Mold concerns would be placed under Health, etc.)
* Health includes asthma, allergic rhinitis, wheeze, cough, shortness of breath, hypersensitivity
pneumonitis, headache, eye and skin problems, and other health issues.
** Proactive includes pre-purchase inspections and samples taken in advance of any observed problem such as
scheduled quarterly or annual preventative samplings, etc.
The entries in the table should total 100% of your samplings.

While our intent is to publish information from these responses as part of the study (for example,
the average percentage of our clients’ samplings that were prompted by Health concerns), no
further information on the identity of the individuals or companies responding will be included in
the publication; this information is only to establish a reference point on how frequently different
issues are observed at the locations sampled by our clients who have performed culture-type air
sampling for fungi in residences.
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While there is no obligation, if you have time, we would certainly appreciate your help on this
important public health research project. Please take a few moments to fill out the table and
return it by 5/14/18.
Feel free to contact me if you have any questions.
Sincerely,
DANIEL DEVINE
Support Systems Manager
EMLab P&K
A TestAmerica Company
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Supplemental Data
S2 - Allergist/Immunologist Questionnaire
Mold Antigen Extracts Used for Skin Testing to Assess Patient Allergic Sensitivity to Mold
Name:

Date:

Which of the following mold antigen extracts do you use?
Fungi

Yes

If yes, from which
Antigen Extract Manufacturer?

No

Alternaria alternata
Aspergillus amstelodami (Aspergillus eurotium)
Aspergillus flavus
Aspergillus fumigatus
Aspergillus nidulans
Aspergillus niger
Aspergillus sydowii
Aspergillus versicolor
Aureobasidium pullulans
Candida albicans
Chaetomium globosum
Cladosporium cladosporioides
Cladosporium herbarum
Cladosporium sphaerospermum
Epicoccum nigrum
Mucor plumbeus
Paecilomyces variotti
Penicillium brevicompactum
Penicillium camembertii
Penicillium chrysogenum (notatum)
Penicillium digitatum
Penicillium expansum
Pen. Mix (notatum, digitum, expansum, roseum)
Rhizopus stolonifer
Rhodotorula mucilaginosa
Other, please specify:
1.
2.
3.

FDA Approved Antigen Extract Manufacturers: StallergenesGreer, HollisterStier, ALK-Abello
Inc., Allergy Laboratories, Allermed Laboratories, Antigen Laboratories
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Supplemental Data
S3 - Commercially Available Mold Antigen Extracts1

Fungus

Esch 2004:
Commercially
available Fungal
Allergen Extracts2

Stallergenes
Greer 2018
Catalog
Fungal
Products3
X

HollisterStier
Allergy 2018
Product
Catalog4

ALK-Abello Inc.
2018
Product Catalog5

Alternaria alternate -Alternaria
X
X
tenuis
Aspergillus amstelodami X
Aspergillus glaucus
Aspergillus flavus
X
Aspergillus fumigatus
X
X
X
Aspergillus nidulans
X
Aspergillus niger
X
X
Aspergillus terreus
X
Aspergillus versicolor
X
Aureobasidium pullulans X
X
Pullularia pullulans
Botrytis cinerea
X
X
X
Chaetomium globosum
X
X
Cladosporium herbarum
X
X
Cladosporium sphaerospermum X
X
Hormodendrum hordei
Cladosporium cladosporoides X
X
Hormodendrum cladosporoides
Curvularia lunata
X
Epicoccum nigrum - Epicoccum
X
X
X
purpurascens
Fusarium solani
X
X
Mucor plumbeus
X
X
Paecilomyces variotii
X
X
Penicillium brevi-compactum
X
Penicillium camembertii
X
Penicillium chrysogenum (notatum)
X
X
X6
Penicillium digitatum
X
X
Penicillium expansum
X
Penicillium roquefortii
X
Rhizopus stolonifera -Rhizopus
X
X
X
nigricans
1
For genera/species representing ≥0.5% of total fungal organisms detected in the indoor or outdoor air
2
See ref
3
http://greerlabs.com/
4
http://www.hsallergy.com/
5
https://www.alk.net/us/
6
Penicillium notatum (Penicillium mix: P. digitatum, P. expansum, P. roseum and P. notatum)
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X

X

X
X

X

X

X

X

Supplemental Data
S4 - Statistical Analysis
The average CFU/m3 for each genus/species represents the arithmetic mean as the focus of this
study was on the elevated levels of various genera and species of mold likely to be found in
complaint homes, hence using the geometric mean or log-normalizing the CFU/m3 data would
effectively diminish the contribution of true outliers that are likely to occur in complaint homes.
We therefore constructed spreadsheets for each species of Aspergillus and Penicillium (from the
full-speciation dataset) and from each species of Aspergillus (from the Aspergillus-only data set)
and isolated each sample that was >3 standard deviations above the arithmetic mean. Each of
these anomalies were then individually investigated to determine the contextual reasonability of
the sample results whereby we discovered only two instances where the results were deemed to
be erroneous resulting in the elimination of theses samples from the final datasets and the
statistical calculations.
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Supplemental Data
S5 - Comparison of Indoor and Outdoor Data for Species where
Indoor or Outdoor Air Represent ≥0.5% of Total Organisms1
Fungi
Average
CFU/m3
Alternaria alternata
Aspergillus flavus
Aspergillus fumigatus
Aspergillus glaucus
Aspergillus niger
Aspergillus ochraceus
Aspergillus sydowii
Aspergillus ustus
Aspergillus versicolor
Aureobasidium pullulans
Basidiomycetes
Botrytis cinerea
Chaetomium globosum
Cladosporium cladosporioides
Cladosporium herbarum
Cladosporium sphaerospermum
Curvularia lunata
Epicoccum nigrum
Fusarium solani
Mucor plumbeus
Non-sporulating fungi
Paecilomyces variotii
Penicillium
Penicillium aurantiogriseum
Penicillium brevicompactum
Penicillium chrysogenum
Penicillium citrinum
Penicillium corylophilum
Penicillium crustosum
Penicillium decumbens
Penicillium expansum
Penicillium glabrum
Penicillium lividum
Penicillium minioluteum
Penicillium oxalicum
Penicillium purpurogenum
Penicillium sclerotiorum
Penicillium sp.
Penicillium variabile
Pithomyces chartarum
Rhizopus stolonifer
Trichoderma koningii
Ulocladium botrytis
Yeasts

22.3
33.8
22.2
188.3
61.4
56.1
196.7
68.6
185.4
30.5
52.6
11.3
17.7
206.7
312.6
148.8
27.7
24.0
14.2
14.7
22.2
16.8
59.9
196.3
197.7
73.7
89.9
46.3
171.4
29.0
150.5
55.4
246.3
58.9
82.9
42.1
36.9
42.5
136.1
22.5
14.0
8.5
12.0
15.3

Residential
% Organisms
Percent
≥ 0.5% of
Occurrence
3
Total2
3.54
18.05
0.43
1.82
1.79
7.59
0.52
2.22
4.03
17.13
0.97
4.11
1.35
5.73
0.73
3.1
5.78
24.54
1.56
7.95
3.03
15.46
0.95
4.83
0.89
4.56
15.94
81.41
1.00
5.09
1.10
5.63
1.35
6.88
2.29
11.71
0.21
1.07
0.67
3.40
6.74
34.41
0.89
4.56
0.30
1.52
2.70
13.76
3.15
16.09
2.31
11.80
3.48
17.78
0.84
4.29
2.00
10.19
0.95
4.83
0.58
2.95
1.72
8.76
0.79
4.02
0.88
4.47
0.47
2.41
2.05
10.46
0.53
2.68
0.65
3.31
1.73
8.85
1.03
5.27
1.07
5.45
0.61
3.13
0.53
2.68
0.30
1.52
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Average
CFU/m3
21.4
17.6
23.5
38.3
33.5
19.8
32.9
14.9
37.5
30.1
91.5
11.5
15.5
384.2
314.6
158.4
27.4
25.9
23.9
10.4
18.8
14.9
30.9
61.7
79.8
55.2
34.5
24.6
36.3
28.2
79.5
26.1
37.0
32.8
75.7
52.3
25.4
16.5
29.7
21.5
11.8
8.3
16.0
36.4

Outdoor-Control
% Organisms
Percent
≥ 0.5% of
Occurrence3
Total2
6.10
30.9
0.85
3.76
2.20
9.78
0.24
1.08
5.51
24.51
0.72
3.22
0.24
1.08
0.19
0.86
1.33
5.91
1.64
8.29
5.79
29.31
0.96
4.86
1.01
11.7
16.66
84.42
1.79
9.05
0.78
3.94
0.79
4.02
4.73
23.95
0.69
3.52
0.08
0.42
7.64
38.69
0.71
3.60
0.55
2.76
1.32
6.7
2.74
13.9
1.67
8.46
2.74
13.9
0.56
2.85
1.16
5.86
0.84
4.27
0.15
0.75
1.36
6.87
0.36
1.84
1.02
5.19
1.49
7.54
1.11
5.61
1.09
5.53
0.76
3.85
0.58
2.93
0.91
4.61
0.84
4.27
0.12
0.59
0.33
1.68
1.17
5.95

Yeasts, other
36.4
3.34
17.07
39.0
3.32
16.83
Total Occurrences Asp-only
99,064
125,893
dataset
Total Samples Asp-only dataset
23,336
28,229
Total Projects Asp-only dataset
7,248
18,915
Total Occurrences Full-spec
5,714
6,049
dataset
Total Samples Full-spec dataset
1,119
1,194
Total Projects Full-spec dataset
299
677
1
For Aspergillus genus/species – data from Aspergillus-only dataset; For all other genera/species – data from Full-speciation dataset
2
Percent of this species comprised of total fungal flora
3
Percent of sample in which this species was detected
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Supplemental Data
S6 - Indoor Samples: Rank Order of Predominance for Aspergillus Species
Comparison of Aspergillus-only and Full Speciation Datasets
Aspergillus-only Dataset
Aspergillus species in
Percent Total Fungal
rank order
Organisms
A. versicolor
5.78
A. niger
4.03
A. fumigatus
1.79
A. sydowii
1.35
A. ochraceus
0.97
A. ustus
0.73
A. nidulans
0.43
A. flavus
0.43
Total samples
23,336
Aspergillus-only dataset
Total projects
Aspergillus-only dataset

Full Speciation Dataset
Aspergillus species in
Percent Total Fungal
rank order
Organisms
A. versicolor
4.60
A. niger
3.82
A. fumigatus
1.19
A. nidulans
1.14
A. sydowii
1.03
A. ustus
1.03
A. ochraceus
0.81
A. flavus
0.49
Total samples Full
1,119
Speciation dataset
Total projects Full
Speciation dataset

7,248

299

Comparison of Aspergillus-only and Full Speciation Datasets Indoor Samples
Percent Total Fungal Organisms

6
5.5
5

Aspergillus-only Percent
Total Fungal Organisms

4.5
4

Full Speciation Percent
Total Fungal Organisms

3.5
3
2.5
2
1.5
1
0.5
0

Aspergillus Species
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Supplemental Data
S7 - Outdoor Samples: Rank Order of Predominance for Aspergillus Species
Comparison of Aspergillus-only and Full Speciation Datasets
Aspergillus-only Dataset
Aspergillus species in
Percent Total Fungal
rank order
Organisms
A. niger
5.51
A. fumigatus
2.20
A. versicolor
1.33
A. flavus
0.85
A. ochraceus
0.72
A. nidulans
0.42
A. sydowii
0.24
A. ustus
0.19
Total samples
28,229
Aspergillus-only dataset
Total projects
18,915
Aspergillus-only dataset

Full Speciation Dataset
Aspergillus species
Percent Total Fungal
in rank order
Organisms
A. niger
4.20
A. fumigatus
1.77
A. versicolor
1.54
A. flavus
0.83
A. ochraceus
0.64
A. nidulans
0.51
A. sydowii
0.35
A. ustus
0.17
Total samples Full
1,194
Speciation dataset
Total projects Full
677
Speciation dataset

Comparison of Aspergillus-only and Full Speciation Datasets Outdoor Samples
Percent Total Fungal Organmisms

6
5.5
5

Aspergillus-only
Percent Total Fungal
Organisms

4.5
4
3.5

Full Speciation Percent
Total Fungal Organisms

3
2.5
2
1.5
1
0.5
0

Aspergillus Species
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CHAPTER 5
CONCLUSIONS
The Translational Environmental Research Framework (TERF) discussed in the Introduction
Chapter of this dissertation is driven by lessons learned in our environmental practice and
enabled by our collaborations with environmental and clinical practitioners, the research and
academic communities, NGO’s and government agencies. This framework has powered our
public health initiatives over the past 20 years and has served to inform the research questions,
drive the hypothesis building and enable the conduct of the three studies that form the core of
this dissertation.
The findings from each of these three studies demonstrate that sampling for mold in the indoor
air is a valid and useful tool in assessing exposure risk to atopic occupants in D/M homes. Valid
exposure assessment from both an environmental and clinical standpoint is a critical first step in
recognizing the need for environmental remediation, which research has established is an
effective intervention modality for improving health outcomes. 1,2,3
Now, our job is to work with our collaborators in the environmental, clinical, academic and
research communities to translate the key findings in these studies through actions that will
bridge research gaps and inform changes in health policy and best practices.
The key findings from the Systematic Review (Article 1) are:
1) In 20 of the 21 studies that met our inclusion criteria, a significant association was found
between exposure to “elevated levels” of mold in the indoor air and an adverse
respiratory health outcome, irrespective of how “elevated levels” of indoor airborne mold
were defined. Based on this finding, we conclude that the current body of scientific
evidence does support measuring indoor airborne mold levels as a tool in assessing
respiratory health risk to atopic residents. This finding validates the practices of indoor
environmental consultants who routinely conduct indoor air sampling for mold and use
the results, together with other findings, in providing health protective advice to
occupants of D/M homes.
2) The methods used by researchers for collecting air samples and defining “elevated levels”
of indoor airborne mold in these 21 studies are inconsistent with the methods used by
environmental practitioners in two important ways. First, in 18 of the 21 studies, air
samples for mold were collected and analyzed by culture method, whereas in current
environmental practice, > 90% of air samples for mold are collected and analyzed by
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spore trap method. Second, only three of the 21 studies defined “elevated levels” by
comparing indoor to outdoor levels by genus, as is required of environmental
practitioners. If the goal of establishing dose-response based quantitative HGV’s for
indoor airborne mold is to be achieved, researchers will need to align their study methods
with those in use by practitioners such that study results can be translated into practice
and policy.
3) In 10 of the 21 studies, Penicillium was found to be the genus of mold associated with an
adverse respiratory health outcome as a result of exposure to elevated indoor airborne
mold levels, followed by Cladosporium in five studies (none in the U.S.), Alternaria in
three studies, Aspergillus in two studies, and Basidiospores in two studies. This finding
is especially significant considering the finding from Article 3 of this dissertation (see
below) that the Penicillium species accounting for > 80% of the total fungal structures of
the Penicillium genus in the indoor air of D/M homes are not among the mold antigen
extracts currently used or available for clinical diagnosis of mold allergies.
How are we translating these key findings to bridge research gaps and inform health policy?
1) By building a consensus within the research community that there is an urgent need to
establish dose-response based quantitative minimum risk levels for indoor airborne mold
that can be used by environmental practitioners as a tool in providing health protective
advice to clients and by policy makers for developing quantitative HGV's.
Accomplishing this objective will require:
a. Publishing this systematic review in a high-impact and highly selective journal
that will allow our findings and recommendations the opportunity to resonate with
fellow researchers and practitioners and help to build our network of collaborators
within the environmental practitioner and research communities.
b. Presenting at professional conferences to explain our findings and
recommendations, to encourage discussion and dialogue, and to expand our
network of collaborators within the environmental practitioner and research
communities.
2) By designing and conducting research studies, such as the 34 participant Pilot Study we
conducted in 2016 (Article 2) and the larger 229 participant nested case-control study
that we are currently conducting in Havana, Cuba, both of which are designed to
establish benchmark dose-response based quantitative minimum risk levels for indoor
airborne mold.
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The key findings from the Pilot Study (Article 2) are:
1) Consistent with the key findings from our systematic review as discussed above, in the
Pilot Study, air samples were taken using the sporetrap method, used by environmental
practitioners for > 90% of air samples for mold taken in practice, and results were
interpreted by comparing indoor to outdoor levels by genus, as is required by the AIHA.
Using these methods for air sampling and laboratory results interpretation, this study
found that children exposed to Penicillium/Aspergillus type mold in the indoor air at
levels > 200 str/m3 higher than outdoors were 11 times more likely to experience wheeze
than children exposed to lower levels.
2) Children exposed to Cladosporium in the indoor air at levels > 200 or > 1,000 str/m3
higher than outdoors were no more likely to experience wheeze than children exposed to
lower levels.
3) Levels of Penicillium/Aspergillus in the outdoor air in New York and Havana, Cuba were
found to be within the same range in both geographies and climates. This finding helps to
establish the reliability of the benchmark dose-response based minimum risk level for
indoor airborne Penicillium/Aspergillus found in the Cuba studies for use in studies
conducted in New York, where we are considering conducting additional studies in lowincome housing.

How are we translating these key findings to bridge research gaps and inform health policy?
1) By using the findings from the 2016 Pilot Study to provide further support for our
proceeding with the much larger nested case-control study (n=229), currently underway
in Cuba and where the participants (now 7 and 8 year old children) were selected from
the same Havana birth cohort as were the Pilot Study participants. In this larger study, in
addition to collecting indoor and outdoor air samples for mold using the sporetrap
method, the inspectors are collecting physical data on the homes' conditions, including
the four markers of D/M conditions currently recognized by the WHO as being
associated with adverse respiratory health outcomes (visible mold, visible water damage,
visible or measurable excessive moisture, and moldy/musty odor). This data will be
analyzed to assess the strengths of association between exposure to elevated levels of
indoor airborne mold and these other four D/M markers (individually and in relationship
to one another) and current asthma.
2) By using the lessons learned from the Pilot Study to make improvements in the study
design and thereby the publishability of the 229 home study. These design improvements
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include reducing the elapsed time interval between the determination of disease status
(current asthma or no current asthma) and the time of the home inspections, the results of
which determine the exposure status. Assuring that this time interval is reduced to the
shortest practical interval and that the disease status is determined by a physician in
accordance with consistent criteria for defining current asthma is critical to reducing a
potential threat to the validity of the findings in this study.

The key findings from the Concordance Study (Article 3) are:

1) The database we created of 24,455 culture-type indoor air samples taken from D/M
homes by environmental practitioners across the U.S. and Canada from 2002 to 2017
enabled us to determine that for the Aspergillus genus > 50% and for the Penicillium
genus > 80% of the fungal organisms found in D/M homes are species that are absent
from the antigen extracts used by clinicians to diagnose mold allergies. This discordance
potentially results in under-diagnosis of mold-related symptoms and disease and
consequential failure to recognize the need for environmental assessment and
remediation, which research has demonstrated is an effective intervention modality for
improving health outcomes.1,2,3
2) The impact of potentially underdiagnosing allergic sensitivity to Penicillium in 80% of
patients who may actually be allergic to Penicillium is compounded by our finding in the
Systematic Review (Article 1) that Penicillium was found to be the genus of mold
associated with an adverse respiratory health outcome as a result of exposure to elevated
indoor airborne mold levels in 10 of the 21 studies, contrasted to Cladosporium in five
studies (none in the U.S.), Alternaria in three studies, Aspergillus in only two studies, and
Basidiospores in two studies.
3) The similarity of the composition of the predominant genera and species of molds
detected in culture-type air samples taken from the Eastern and Western U.S. suggests
that the discordance problem is similar throughout the country.
4) Reducing the level of discordance between the species of Penicillium and Aspergillus
type mold found in D/M homes and the species of those molds used in the clinical
diagnosis of mold allergies has significant potential to improve health outcomes by
increasing the recognition of the need for environmental assessment and remediation that
can identify and eliminate exposures that are provoking allergic responses.
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How are we translating these key findings to bridge research gaps and inform best practices?
1) First, by informing clinicians and clinical laboratories that they should be adding two
currently available species-specific mold antigen extracts (A. versicolor and P.
brevicompactum) to the skin testing and serum testing protocols used to assess antibody
response to antigen extract provocation. Second, by building a consensus with clinicians
and clinical laboratories that they need to work with antigen extract manufacturers to
convey the urgent need for the development of species-specific mold antigen extracts for
the other major species of Penicillium (P. aurantiogriseum, P. citrinum, P. crustosum, P.
glabrum, P. purpurogenum and P. variabile) and Aspergillus (A. sydowii) that are
predominant in D/M homes but are currently not available as mold antigen extracts.
Accomplishing this objective will require:
a. Publishing this Concordance article (with the help of our co-author Dr. Robert
Kaner) in a high-impact and highly selective clinical journal (such as Annals of
the American Thoracic Society) that will allow our findings and recommendations
the opportunity to resonate with fellow researchers and practitioners and help to
build our network of collaborators within the clinical practitioner and research
communities.
b. Presenting at professional conferences to explain our findings and
recommendations, to encourage discussion and dialogue, and to expand our
network of collaborators within the clinical practitioner and research
communities.

The Translational Environmental Research Framework (TERF) revolves around a nucleus of
collaborators. The findings from the three studies/articles in this dissertation were made possible
through the collaborative efforts of environmental practitioners, clinical practitioners, and
researchers from academia and government agencies in the U.S., Cuba and Canada, many of
whom are co-authors on one or more of these articles. Similarly, our operationalizing these
findings by forging improvements in environmental and clinical best practices and by informing
health policy is being made possible only through the dedicated support of these collaborators.
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